<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; Quest Diagnostics Inc.</title>
	<atom:link href="http://www.stockbloghub.com/tag/quest-diagnostics-inc/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Fri, 17 May 2013 21:09:17 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.1</generator>
		<item>
		<title>(LIFE) MedTech Industry Stock Update &#8211; May 2013 &#8211; Zacks Analyst Interviews</title>
		<link>http://www.stockbloghub.com/2013/05/15/life-medtech-industry-stock-update-may-2013-zacks-analyst-interviews/136486</link>
		<comments>http://www.stockbloghub.com/2013/05/15/life-medtech-industry-stock-update-may-2013-zacks-analyst-interviews/136486#comments</comments>
		<pubDate>Wed, 15 May 2013 22:34:08 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[A]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[Agilent Technologies Inc]]></category>
		<category><![CDATA[Arizona Land Income Corporation]]></category>
		<category><![CDATA[Athenahealth Inc]]></category>
		<category><![CDATA[ATHN]]></category>
		<category><![CDATA[BAX]]></category>
		<category><![CDATA[Baxter International Inc]]></category>
		<category><![CDATA[BCR]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson And Company]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[Brady Corporation]]></category>
		<category><![CDATA[BRC]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[Conceptus Inc]]></category>
		<category><![CDATA[COO]]></category>
		<category><![CDATA[Corning Inc]]></category>
		<category><![CDATA[COV]]></category>
		<category><![CDATA[Covidien plc]]></category>
		<category><![CDATA[CPTS]]></category>
		<category><![CDATA[Cr Bard Inc]]></category>
		<category><![CDATA[CRM]]></category>
		<category><![CDATA[Danaher Corporation]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[DHR]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[GLW]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[Health Management Associates Inc]]></category>
		<category><![CDATA[HMA]]></category>
		<category><![CDATA[Hologic Inc]]></category>
		<category><![CDATA[HOLX]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Laboratory Corporation of America Holdings]]></category>
		<category><![CDATA[LH]]></category>
		<category><![CDATA[LIFE]]></category>
		<category><![CDATA[Life Technologies Corporation]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[OFIX]]></category>
		<category><![CDATA[Orthofix International NV]]></category>
		<category><![CDATA[Pall Corporation]]></category>
		<category><![CDATA[PCE]]></category>
		<category><![CDATA[PLL]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>
		<category><![CDATA[Salesforce.com]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[TER]]></category>
		<category><![CDATA[Teradyne Inc.]]></category>
		<category><![CDATA[The Cooper Companies Inc]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>
		<category><![CDATA[VASC]]></category>
		<category><![CDATA[Vascular Solutions Inc]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=136486</guid>
		<description><![CDATA[As expected, MedTech mergers and acquisitions (M&#38;A) are heating up in 2013. Finally, the much-hyped takeover battle for Life Technologies Corporation (LIFE) came to an end last month with Thermo Fisher Scientific (TMO) emerging as the clear winner. For most of the last seven years, Thermo Fisher has supported its business momentum by acquiring several entities. Nevertheless, the proposed acquisition of Life Technologies is the biggest-ever deal for the company since its inception in 2006. The takeover will inevitably strengthen Thermo Fisher’s global foothold and commercial reach. It&#8217;s a Buyer’s Market Medical device M&#38;As are not stopping there. Wary of an uncertain economy, MedTech companies have resorted to the acquisition route to harness their strength and diversify offerings. Last month, in a bid to strengthen its contraceptive portfolio, Bayer (BAYRY) ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2013/05/15/life-medtech-industry-stock-update-may-2013-zacks-analyst-interviews/136486/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DGX) Quest Diagnostics Downgraded to Underperform</title>
		<link>http://www.stockbloghub.com/2013/02/11/dgx-quest-diagnostics-downgraded-to-underperform/127868</link>
		<comments>http://www.stockbloghub.com/2013/02/11/dgx-quest-diagnostics-downgraded-to-underperform/127868#comments</comments>
		<pubDate>Mon, 11 Feb 2013 15:28:07 +0000</pubDate>
		<dc:creator>Shawn</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Laboratories & Research]]></category>
		<category><![CDATA[Cyberonics Inc]]></category>
		<category><![CDATA[CYBX]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[EPS]]></category>
		<category><![CDATA[Merit Medical Systems Inc]]></category>
		<category><![CDATA[MMSI]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>
		<category><![CDATA[Resmed Inc]]></category>
		<category><![CDATA[RMD]]></category>
		<category><![CDATA[WisdomTree Earnings 500]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=127868</guid>
		<description><![CDATA[On Feb 1, we downgraded Quest Diagnostics (DGX), a leading player in the diagnostic testing market, to Underperform based on the company’s dismal fourth-quarter 2012 results as well as a disappointing outlook for first quarter 2013. Why the Downgrade? Quest Diagnostics reported adjusted earnings per share (EPS) from continuing operations of $1.01, down 15.8% year over year, missing the Zacks Consensus Estimate of $1.06. This does not exclude the impact of Hurricane Sandy that reduced the EPS by 6 cents. Revenues from continuing operations for the fourth quarter were down 4.0% year over year to $1.77 billion, missing the Zacks Consensus Estimate of $1.82 billion. The first-quarter 2013 guidance was also disappointing and missed our expectation. Following the release of the fourth-quarter results, the Zacks Consensus Estimates for 2013 and ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2013/02/11/dgx-quest-diagnostics-downgraded-to-underperform/127868/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(JNJ) MedTech Industry Stock Outlook &#8211; January 2013 &#8211; Zacks Analyst Interviews</title>
		<link>http://www.stockbloghub.com/2013/01/31/jnj-medtech-industry-stock-outlook-january-2013-zacks-analyst-interviews/127562</link>
		<comments>http://www.stockbloghub.com/2013/01/31/jnj-medtech-industry-stock-outlook-january-2013-zacks-analyst-interviews/127562#comments</comments>
		<pubDate>Thu, 31 Jan 2013 19:55:35 +0000</pubDate>
		<dc:creator>Shawn</dc:creator>
				<category><![CDATA[Drug Manufacturers - Major]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[A]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[Agilent Technologies Inc]]></category>
		<category><![CDATA[AngioDynamics Inc]]></category>
		<category><![CDATA[ANGO]]></category>
		<category><![CDATA[Athenahealth Inc]]></category>
		<category><![CDATA[ATHN]]></category>
		<category><![CDATA[BCR]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson And Company]]></category>
		<category><![CDATA[BMY]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[Bristol-Myers Squibb Company]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CELG]]></category>
		<category><![CDATA[Celgene Corporation]]></category>
		<category><![CDATA[COO]]></category>
		<category><![CDATA[Corning Inc]]></category>
		<category><![CDATA[COV]]></category>
		<category><![CDATA[Covidien plc]]></category>
		<category><![CDATA[Cr Bard Inc]]></category>
		<category><![CDATA[CRM]]></category>
		<category><![CDATA[Danaher Corporation]]></category>
		<category><![CDATA[DENTSPLY International Inc]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[DHR]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[Eli Lilly & Company]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[GILD]]></category>
		<category><![CDATA[Gilead Sciences Inc]]></category>
		<category><![CDATA[Glaxosmithkline plc]]></category>
		<category><![CDATA[GLW]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[Hologic Inc]]></category>
		<category><![CDATA[HOLX]]></category>
		<category><![CDATA[Invacare Corporation]]></category>
		<category><![CDATA[IVC]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Laboratory Corporation of America Holdings]]></category>
		<category><![CDATA[LH]]></category>
		<category><![CDATA[LIFE]]></category>
		<category><![CDATA[Life Technologies Corporation]]></category>
		<category><![CDATA[LLY]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[Merck & Company Inc]]></category>
		<category><![CDATA[MRK]]></category>
		<category><![CDATA[MYL]]></category>
		<category><![CDATA[Mylan Inc.]]></category>
		<category><![CDATA[Pall Corporation]]></category>
		<category><![CDATA[Patterson Companies Inc.]]></category>
		<category><![CDATA[PDCO]]></category>
		<category><![CDATA[PFE]]></category>
		<category><![CDATA[Pfizer Inc.]]></category>
		<category><![CDATA[PLL]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>
		<category><![CDATA[Salesforce.com]]></category>
		<category><![CDATA[Sanofi-Aventis]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[SNY]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[TER]]></category>
		<category><![CDATA[Teradyne Inc.]]></category>
		<category><![CDATA[TEVA]]></category>
		<category><![CDATA[Teva Pharmaceutical Industries Limited]]></category>
		<category><![CDATA[The Cooper Companies Inc]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>
		<category><![CDATA[Vertex Pharmaceuticals Incorporated]]></category>
		<category><![CDATA[VRTX]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[XRAY]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=127562</guid>
		<description><![CDATA[We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the worldwide medical devices market. The US still holds the leading position with almost one-third of the market share. However, emerging economies like Brazil, Russia, India and China – collectively known as the BRICs – are fast coming up in the medical devices space and are attracting a lot of attention. These emerging economies are seeing an increasing uptake of medical devices due largely to growing medical awareness and economic prosperity.  Expansion in emerging markets, especially those with double-digit annual growth rates, represents one of the best potential avenues for growth in 2013 and beyond. On the flip side,  the MedTech industry is currently plagued by several issues ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2013/01/31/jnj-medtech-industry-stock-outlook-january-2013-zacks-analyst-interviews/127562/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AAPL) Fourth Quarter 2012 Earnings Season Gets Into High Gear &#8211; Earnings Preview</title>
		<link>http://www.stockbloghub.com/2013/01/20/aapl-fourth-quarter-2012-earnings-season-gets-into-high-gear-earnings-preview/126708</link>
		<comments>http://www.stockbloghub.com/2013/01/20/aapl-fourth-quarter-2012-earnings-season-gets-into-high-gear-earnings-preview/126708#comments</comments>
		<pubDate>Sun, 20 Jan 2013 17:56:37 +0000</pubDate>
		<dc:creator>Shawn</dc:creator>
				<category><![CDATA[Personal Computers]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[3M Company]]></category>
		<category><![CDATA[8x8 Inc]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABC]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[ACAT]]></category>
		<category><![CDATA[Advanced Micro Devices Inc.]]></category>
		<category><![CDATA[AEP Industries Inc.]]></category>
		<category><![CDATA[AEPI]]></category>
		<category><![CDATA[AF]]></category>
		<category><![CDATA[Air Products & Chemicals Inc.]]></category>
		<category><![CDATA[Airgas Inc.]]></category>
		<category><![CDATA[Alaska Air Group Inc.]]></category>
		<category><![CDATA[ALB]]></category>
		<category><![CDATA[Albemarle Corporation]]></category>
		<category><![CDATA[ALK]]></category>
		<category><![CDATA[Allegheny Technologies Inc]]></category>
		<category><![CDATA[Altera Corporation]]></category>
		<category><![CDATA[ALTR]]></category>
		<category><![CDATA[AMD]]></category>
		<category><![CDATA[AME]]></category>
		<category><![CDATA[American River Bankshares]]></category>
		<category><![CDATA[AmerisourceBergen Corporation]]></category>
		<category><![CDATA[Ametek Inc.]]></category>
		<category><![CDATA[Amgen Inc]]></category>
		<category><![CDATA[AMGN]]></category>
		<category><![CDATA[AMRB]]></category>
		<category><![CDATA[AMTD]]></category>
		<category><![CDATA[Anaren Inc.]]></category>
		<category><![CDATA[ANEN]]></category>
		<category><![CDATA[AO Smith Corporation]]></category>
		<category><![CDATA[AOS]]></category>
		<category><![CDATA[APD]]></category>
		<category><![CDATA[Apple Inc.]]></category>
		<category><![CDATA[Arctic Cat Inc]]></category>
		<category><![CDATA[ARG]]></category>
		<category><![CDATA[Astoria Financial Corporation]]></category>
		<category><![CDATA[AT&T Inc.]]></category>
		<category><![CDATA[ATI]]></category>
		<category><![CDATA[Avnet Inc.]]></category>
		<category><![CDATA[AVT]]></category>
		<category><![CDATA[AVX]]></category>
		<category><![CDATA[AVX Corporation]]></category>
		<category><![CDATA[Baker Hughes Inc.]]></category>
		<category><![CDATA[BancorpSouth Inc.]]></category>
		<category><![CDATA[Bank of Marin Bancorp]]></category>
		<category><![CDATA[Banner Corporation]]></category>
		<category><![CDATA[BANR]]></category>
		<category><![CDATA[BAX]]></category>
		<category><![CDATA[Baxter International Inc]]></category>
		<category><![CDATA[BC]]></category>
		<category><![CDATA[BGG]]></category>
		<category><![CDATA[BHI]]></category>
		<category><![CDATA[BMRC]]></category>
		<category><![CDATA[BMTC]]></category>
		<category><![CDATA[BMY]]></category>
		<category><![CDATA[BPOP]]></category>
		<category><![CDATA[Briggs & Stratton Corporation]]></category>
		<category><![CDATA[Brinker International Inc.]]></category>
		<category><![CDATA[Bristol-Myers Squibb Company]]></category>
		<category><![CDATA[Brunswick Corporation]]></category>
		<category><![CDATA[Bryn Mawr Bank Corporation]]></category>
		<category><![CDATA[BXS]]></category>
		<category><![CDATA[CA]]></category>
		<category><![CDATA[CA Inc.]]></category>
		<category><![CDATA[Cabot Microelectronics Corporation]]></category>
		<category><![CDATA[Canadian National Railway Company]]></category>
		<category><![CDATA[Cathay General Bancorp]]></category>
		<category><![CDATA[CATY]]></category>
		<category><![CDATA[CBST]]></category>
		<category><![CDATA[CBU]]></category>
		<category><![CDATA[CCI]]></category>
		<category><![CDATA[CCMP]]></category>
		<category><![CDATA[Celestica Inc.]]></category>
		<category><![CDATA[CELG]]></category>
		<category><![CDATA[Celgene Corporation]]></category>
		<category><![CDATA[Check Point Software Technologies Limited]]></category>
		<category><![CDATA[CHKP]]></category>
		<category><![CDATA[Cirrus Logic Inc.]]></category>
		<category><![CDATA[Citizens Republic Bancorp Inc]]></category>
		<category><![CDATA[City National Corporation]]></category>
		<category><![CDATA[CLP]]></category>
		<category><![CDATA[CLS]]></category>
		<category><![CDATA[CMCO]]></category>
		<category><![CDATA[CNI]]></category>
		<category><![CDATA[CNS]]></category>
		<category><![CDATA[Coach Inc.]]></category>
		<category><![CDATA[CoBiz Financial Inc]]></category>
		<category><![CDATA[COBZ]]></category>
		<category><![CDATA[COH]]></category>
		<category><![CDATA[Cohen & Steers Inc.]]></category>
		<category><![CDATA[Coherent Inc]]></category>
		<category><![CDATA[COHR]]></category>
		<category><![CDATA[COLB]]></category>
		<category><![CDATA[Colonial Properties Trust]]></category>
		<category><![CDATA[Columbia Banking System Inc]]></category>
		<category><![CDATA[Columbus Mckinnon Corporation]]></category>
		<category><![CDATA[Community Bank System Inc]]></category>
		<category><![CDATA[Compuware Corporation]]></category>
		<category><![CDATA[Consolidated Edison Inc.]]></category>
		<category><![CDATA[Courier Corporation]]></category>
		<category><![CDATA[COV]]></category>
		<category><![CDATA[Covance Inc.]]></category>
		<category><![CDATA[Covidien plc]]></category>
		<category><![CDATA[CPWR]]></category>
		<category><![CDATA[CRBC]]></category>
		<category><![CDATA[CREE]]></category>
		<category><![CDATA[Cree Inc.]]></category>
		<category><![CDATA[Crown Castle International Corporation]]></category>
		<category><![CDATA[CRRC]]></category>
		<category><![CDATA[CRUS]]></category>
		<category><![CDATA[CSX]]></category>
		<category><![CDATA[CSX Corporation]]></category>
		<category><![CDATA[Cubist Pharmaceuticals Inc.]]></category>
		<category><![CDATA[CVD]]></category>
		<category><![CDATA[CY]]></category>
		<category><![CDATA[CYN]]></category>
		<category><![CDATA[Cypress Semiconductor Corporation]]></category>
		<category><![CDATA[DAL]]></category>
		<category><![CDATA[DCOM]]></category>
		<category><![CDATA[DD]]></category>
		<category><![CDATA[Delta Air Lines Inc.]]></category>
		<category><![CDATA[Deluxe Corporation]]></category>
		<category><![CDATA[DGII]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[Digi International Inc.]]></category>
		<category><![CDATA[Dime Community Bancshares Inc]]></category>
		<category><![CDATA[DLLR]]></category>
		<category><![CDATA[DLX]]></category>
		<category><![CDATA[Dollar Financial Corporation]]></category>
		<category><![CDATA[DOV]]></category>
		<category><![CDATA[Dover Corporation]]></category>
		<category><![CDATA[E*TRADE Financial Corporation]]></category>
		<category><![CDATA[Eagle Bancorp Inc]]></category>
		<category><![CDATA[East West Bancorp Inc]]></category>
		<category><![CDATA[EAT]]></category>
		<category><![CDATA[ED]]></category>
		<category><![CDATA[EFII]]></category>
		<category><![CDATA[EGBN]]></category>
		<category><![CDATA[EGHT]]></category>
		<category><![CDATA[EGN]]></category>
		<category><![CDATA[EI DuPont de Nemours & Company]]></category>
		<category><![CDATA[Electronics for Imaging Inc.]]></category>
		<category><![CDATA[Energen Corporation]]></category>
		<category><![CDATA[EQT]]></category>
		<category><![CDATA[EQT Corporation]]></category>
		<category><![CDATA[ESI]]></category>
		<category><![CDATA[ETFC]]></category>
		<category><![CDATA[ETH]]></category>
		<category><![CDATA[Ethan Allen Interiors Inc.]]></category>
		<category><![CDATA[EWBC]]></category>
		<category><![CDATA[EXAR]]></category>
		<category><![CDATA[Exar Corporation]]></category>
		<category><![CDATA[EZCORP Inc.]]></category>
		<category><![CDATA[EZPW]]></category>
		<category><![CDATA[F.N.B. Corporation]]></category>
		<category><![CDATA[F5 Networks Inc.]]></category>
		<category><![CDATA[Fairchild Semiconductor International Inc]]></category>
		<category><![CDATA[FBC]]></category>
		<category><![CDATA[FCFS]]></category>
		<category><![CDATA[FCS]]></category>
		<category><![CDATA[FCX]]></category>
		<category><![CDATA[Federated Investors Inc]]></category>
		<category><![CDATA[FFCH]]></category>
		<category><![CDATA[FFIV]]></category>
		<category><![CDATA[FII]]></category>
		<category><![CDATA[First Cash Financial Services Inc]]></category>
		<category><![CDATA[First Financial Holdings Inc]]></category>
		<category><![CDATA[First Merchants Corporation]]></category>
		<category><![CDATA[First Midwest Bancorp Inc]]></category>
		<category><![CDATA[FirstMerit Corporation]]></category>
		<category><![CDATA[Flagstar Bancorp Inc]]></category>
		<category><![CDATA[FLEX]]></category>
		<category><![CDATA[Flextronics International Limited]]></category>
		<category><![CDATA[FMBI]]></category>
		<category><![CDATA[FMER]]></category>
		<category><![CDATA[FNB]]></category>
		<category><![CDATA[Freeport-McMoRan Copper & Gold Inc]]></category>
		<category><![CDATA[FRME]]></category>
		<category><![CDATA[GATX Corporation]]></category>
		<category><![CDATA[GBCI]]></category>
		<category><![CDATA[GD]]></category>
		<category><![CDATA[General Dynamics Corporation]]></category>
		<category><![CDATA[Glacier Bancorp Inc]]></category>
		<category><![CDATA[GMT]]></category>
		<category><![CDATA[GOOG]]></category>
		<category><![CDATA[Google Inc.]]></category>
		<category><![CDATA[GWW]]></category>
		<category><![CDATA[HAFC]]></category>
		<category><![CDATA[HAL]]></category>
		<category><![CDATA[Halliburton Company]]></category>
		<category><![CDATA[Hancock Holding Company]]></category>
		<category><![CDATA[Hanmi Financial Corporation]]></category>
		<category><![CDATA[HBHC]]></category>
		<category><![CDATA[HEOP]]></category>
		<category><![CDATA[Heritage Oaks Bancorp]]></category>
		<category><![CDATA[Hexcel Corporation]]></category>
		<category><![CDATA[Hill-rom Holdings Inc]]></category>
		<category><![CDATA[HON]]></category>
		<category><![CDATA[Honeywell International Inc.]]></category>
		<category><![CDATA[HRC]]></category>
		<category><![CDATA[HUBB]]></category>
		<category><![CDATA[Hubbell Inc B Shares]]></category>
		<category><![CDATA[HXL]]></category>
		<category><![CDATA[IberiaBank Corporation]]></category>
		<category><![CDATA[IBKC]]></category>
		<category><![CDATA[IBM]]></category>
		<category><![CDATA[IGT]]></category>
		<category><![CDATA[II-VI Inc]]></category>
		<category><![CDATA[IIVI]]></category>
		<category><![CDATA[IMGN]]></category>
		<category><![CDATA[Immunogen Inc]]></category>
		<category><![CDATA[INDB]]></category>
		<category><![CDATA[Independent Bank Corporation]]></category>
		<category><![CDATA[INFA]]></category>
		<category><![CDATA[Informatica Corporation]]></category>
		<category><![CDATA[INTC]]></category>
		<category><![CDATA[Intel Corporation]]></category>
		<category><![CDATA[International Business Machines Corporation]]></category>
		<category><![CDATA[International Game Technology]]></category>
		<category><![CDATA[International Speedway Corporation]]></category>
		<category><![CDATA[Intuitive Surgical Inc]]></category>
		<category><![CDATA[Invesco Limited]]></category>
		<category><![CDATA[ISCA]]></category>
		<category><![CDATA[ISRG]]></category>
		<category><![CDATA[Iteris Inc]]></category>
		<category><![CDATA[ITI]]></category>
		<category><![CDATA[ITT Educational Services Inc.]]></category>
		<category><![CDATA[IVZ]]></category>
		<category><![CDATA[Jacobs Engineering Group Inc.]]></category>
		<category><![CDATA[Janus Capital Group Inc.]]></category>
		<category><![CDATA[JB Hunt Transport Services Inc]]></category>
		<category><![CDATA[JBHT]]></category>
		<category><![CDATA[JEC]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[JNPR]]></category>
		<category><![CDATA[JNS]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Juniper Networks Inc.]]></category>
		<category><![CDATA[Kansas City Southern]]></category>
		<category><![CDATA[Kennametal Inc.]]></category>
		<category><![CDATA[KEY]]></category>
		<category><![CDATA[Key Technology Inc]]></category>
		<category><![CDATA[KeyCorp]]></category>
		<category><![CDATA[Kimberly-Clark Corporation]]></category>
		<category><![CDATA[KLA-Tencor Corporation]]></category>
		<category><![CDATA[KLAC]]></category>
		<category><![CDATA[KMB]]></category>
		<category><![CDATA[KMT]]></category>
		<category><![CDATA[KSU]]></category>
		<category><![CDATA[KTEC]]></category>
		<category><![CDATA[Lam Research Corporation]]></category>
		<category><![CDATA[Lattice Semiconductor Corporation]]></category>
		<category><![CDATA[LCC]]></category>
		<category><![CDATA[LG Display Company Limited]]></category>
		<category><![CDATA[LMT]]></category>
		<category><![CDATA[Lockheed Martin Corporation]]></category>
		<category><![CDATA[LOGI]]></category>
		<category><![CDATA[Logitech International SA]]></category>
		<category><![CDATA[LPL]]></category>
		<category><![CDATA[LRCX]]></category>
		<category><![CDATA[LSCC]]></category>
		<category><![CDATA[LSI]]></category>
		<category><![CDATA[LSI Corporation]]></category>
		<category><![CDATA[LSI Industries Inc.]]></category>
		<category><![CDATA[LUV]]></category>
		<category><![CDATA[LYTS]]></category>
		<category><![CDATA[Marine Products Corporation]]></category>
		<category><![CDATA[Marten Transport Limited]]></category>
		<category><![CDATA[Maxim Integrated Products Inc]]></category>
		<category><![CDATA[MCBI]]></category>
		<category><![CDATA[McCormick & Company Inc]]></category>
		<category><![CDATA[MCD]]></category>
		<category><![CDATA[McDonald's Corporation]]></category>
		<category><![CDATA[MCRS]]></category>
		<category><![CDATA[MDP]]></category>
		<category><![CDATA[Mellanox Technologies Limited]]></category>
		<category><![CDATA[Meredith Corporation]]></category>
		<category><![CDATA[Metrocorp Bancshares Inc.]]></category>
		<category><![CDATA[Micros Systems Inc.]]></category>
		<category><![CDATA[Microsoft Corporation]]></category>
		<category><![CDATA[MKC]]></category>
		<category><![CDATA[MLNX]]></category>
		<category><![CDATA[MMM]]></category>
		<category><![CDATA[MOGA]]></category>
		<category><![CDATA[Molex Inc.]]></category>
		<category><![CDATA[MOLX]]></category>
		<category><![CDATA[Moog Incorporated]]></category>
		<category><![CDATA[Motorola Solutions]]></category>
		<category><![CDATA[MPX]]></category>
		<category><![CDATA[MRTN]]></category>
		<category><![CDATA[MSFT]]></category>
		<category><![CDATA[MSI]]></category>
		<category><![CDATA[MXIM]]></category>
		<category><![CDATA[National Penn Bancshares Inc]]></category>
		<category><![CDATA[NE]]></category>
		<category><![CDATA[Netflix Inc.]]></category>
		<category><![CDATA[NFLX]]></category>
		<category><![CDATA[Noble Corporation]]></category>
		<category><![CDATA[NOK]]></category>
		<category><![CDATA[Nokia Corporation]]></category>
		<category><![CDATA[Norfolk Southern Corporation]]></category>
		<category><![CDATA[Novartis AG]]></category>
		<category><![CDATA[NPBC]]></category>
		<category><![CDATA[NSC]]></category>
		<category><![CDATA[NVE Corporation]]></category>
		<category><![CDATA[NVEC]]></category>
		<category><![CDATA[NVS]]></category>
		<category><![CDATA[OceanFirst Financial Corporation]]></category>
		<category><![CDATA[OCFC]]></category>
		<category><![CDATA[Old Republic International Corporation]]></category>
		<category><![CDATA[OMN]]></category>
		<category><![CDATA[OMNOVA Solutions Inc.]]></category>
		<category><![CDATA[Open Text Corporation]]></category>
		<category><![CDATA[ORI]]></category>
		<category><![CDATA[Oshkosh Corporation]]></category>
		<category><![CDATA[OSK]]></category>
		<category><![CDATA[OTEX]]></category>
		<category><![CDATA[Pacific Premier Bancorp Inc]]></category>
		<category><![CDATA[Packaging Corporation of America]]></category>
		<category><![CDATA[Parametric Technology Corporation]]></category>
		<category><![CDATA[PCP]]></category>
		<category><![CDATA[PEBO]]></category>
		<category><![CDATA[Peoples Bancorp Inc]]></category>
		<category><![CDATA[PetMed Express Inc.]]></category>
		<category><![CDATA[PETS]]></category>
		<category><![CDATA[PFBC]]></category>
		<category><![CDATA[PG]]></category>
		<category><![CDATA[PKG]]></category>
		<category><![CDATA[PLCM]]></category>
		<category><![CDATA[PMTC]]></category>
		<category><![CDATA[Polycom Inc.]]></category>
		<category><![CDATA[Popular Inc]]></category>
		<category><![CDATA[PPBI]]></category>
		<category><![CDATA[Praxair Inc.]]></category>
		<category><![CDATA[Precision Castparts Corporation]]></category>
		<category><![CDATA[Preferred Bank]]></category>
		<category><![CDATA[Premierwest Bancorp]]></category>
		<category><![CDATA[Privatebancorp Inc]]></category>
		<category><![CDATA[Procter & Gamble Company]]></category>
		<category><![CDATA[PRWT]]></category>
		<category><![CDATA[PVTB]]></category>
		<category><![CDATA[PX]]></category>
		<category><![CDATA[QLGC]]></category>
		<category><![CDATA[QLogic Corporation]]></category>
		<category><![CDATA[QSII]]></category>
		<category><![CDATA[Quality Systems Inc.]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>
		<category><![CDATA[Raymond James Financial Inc.]]></category>
		<category><![CDATA[Rayonier Inc.]]></category>
		<category><![CDATA[Raytheon Company]]></category>
		<category><![CDATA[Regions Financial Corporation]]></category>
		<category><![CDATA[RES]]></category>
		<category><![CDATA[Resmed Inc]]></category>
		<category><![CDATA[RF]]></category>
		<category><![CDATA[RF Micro Devices Inc.]]></category>
		<category><![CDATA[RFMD]]></category>
		<category><![CDATA[RJF]]></category>
		<category><![CDATA[RKT]]></category>
		<category><![CDATA[RLI]]></category>
		<category><![CDATA[RLI Corporation]]></category>
		<category><![CDATA[RMD]]></category>
		<category><![CDATA[Rock-Tenn Company]]></category>
		<category><![CDATA[ROL]]></category>
		<category><![CDATA[Rollins Inc]]></category>
		<category><![CDATA[RPC Inc.]]></category>
		<category><![CDATA[RTN]]></category>
		<category><![CDATA[RYN]]></category>
		<category><![CDATA[SanDisk Corporation]]></category>
		<category><![CDATA[Sandy Spring Bancorp Inc]]></category>
		<category><![CDATA[SAP]]></category>
		<category><![CDATA[Sap Ag]]></category>
		<category><![CDATA[SASR]]></category>
		<category><![CDATA[SBCF]]></category>
		<category><![CDATA[SBUX]]></category>
		<category><![CDATA[ScanSource Inc.]]></category>
		<category><![CDATA[SCSC]]></category>
		<category><![CDATA[SCSS]]></category>
		<category><![CDATA[Seacoast Banking Corporation of Florida]]></category>
		<category><![CDATA[Sealy Corporation]]></category>
		<category><![CDATA[Select Comfort Corporation]]></category>
		<category><![CDATA[SFNC]]></category>
		<category><![CDATA[SILC]]></category>
		<category><![CDATA[Silicom Limited]]></category>
		<category><![CDATA[Simmons First National Corporation]]></category>
		<category><![CDATA[SMCI]]></category>
		<category><![CDATA[SNDK]]></category>
		<category><![CDATA[SNV]]></category>
		<category><![CDATA[Southwest Airlines Company]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[Stanley Works]]></category>
		<category><![CDATA[Starbucks Corporation]]></category>
		<category><![CDATA[STEL]]></category>
		<category><![CDATA[StellarOne Corporation]]></category>
		<category><![CDATA[Sterling Financial Corporation]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Strattec Security Corporation]]></category>
		<category><![CDATA[STRT]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[STSA]]></category>
		<category><![CDATA[Super Micro Computer Inc]]></category>
		<category><![CDATA[Supertex Inc.]]></category>
		<category><![CDATA[SUPX]]></category>
		<category><![CDATA[SUSQ]]></category>
		<category><![CDATA[Susquehanna Bancshares Inc]]></category>
		<category><![CDATA[SWK]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symantec Corporation]]></category>
		<category><![CDATA[SYMC]]></category>
		<category><![CDATA[SYMM]]></category>
		<category><![CDATA[Symmetricom Inc]]></category>
		<category><![CDATA[SYNA]]></category>
		<category><![CDATA[Synaptics Inc]]></category>
		<category><![CDATA[Synovus Financial Corporation]]></category>
		<category><![CDATA[T]]></category>
		<category><![CDATA[TAYC]]></category>
		<category><![CDATA[Taylor Capital Group Inc]]></category>
		<category><![CDATA[TBBK]]></category>
		<category><![CDATA[TCBI]]></category>
		<category><![CDATA[TD AMERITRADE Holding Corporation]]></category>
		<category><![CDATA[TEL]]></category>
		<category><![CDATA[Tempur Pedic International Inc]]></category>
		<category><![CDATA[TER]]></category>
		<category><![CDATA[Teradyne Inc.]]></category>
		<category><![CDATA[Texas Capital BancShares Inc.]]></category>
		<category><![CDATA[Texas Instruments Inc.]]></category>
		<category><![CDATA[Textron Inc.]]></category>
		<category><![CDATA[The Bancorp Inc]]></category>
		<category><![CDATA[The Travelers Companies Inc.]]></category>
		<category><![CDATA[Timken Company]]></category>
		<category><![CDATA[TKR]]></category>
		<category><![CDATA[Total System Services Inc]]></category>
		<category><![CDATA[TPX]]></category>
		<category><![CDATA[TRMK]]></category>
		<category><![CDATA[TRST]]></category>
		<category><![CDATA[TrustCo Bank Corporation NY]]></category>
		<category><![CDATA[Trustmark Corporation]]></category>
		<category><![CDATA[TRV]]></category>
		<category><![CDATA[TSS]]></category>
		<category><![CDATA[TUES]]></category>
		<category><![CDATA[Tuesday Morning Corporation]]></category>
		<category><![CDATA[TWIN]]></category>
		<category><![CDATA[Twin Disc Inc.]]></category>
		<category><![CDATA[TXN]]></category>
		<category><![CDATA[TXT]]></category>
		<category><![CDATA[Tyco Electronics Limited]]></category>
		<category><![CDATA[UCBI]]></category>
		<category><![CDATA[UFI]]></category>
		<category><![CDATA[UMB Financial Corporation]]></category>
		<category><![CDATA[UMBF]]></category>
		<category><![CDATA[UMPQ]]></category>
		<category><![CDATA[Umpqua Holdings Corporation]]></category>
		<category><![CDATA[Unifi Inc]]></category>
		<category><![CDATA[Union Pacific Corporation]]></category>
		<category><![CDATA[United Community Banks Inc]]></category>
		<category><![CDATA[United Rentals Inc]]></category>
		<category><![CDATA[United Technologies Corporation]]></category>
		<category><![CDATA[UNP]]></category>
		<category><![CDATA[UPI]]></category>
		<category><![CDATA[URI]]></category>
		<category><![CDATA[Uroplasty Inc]]></category>
		<category><![CDATA[US Airways Group Inc.]]></category>
		<category><![CDATA[UTX]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VeriSign Inc.]]></category>
		<category><![CDATA[Verizon Communications Inc.]]></category>
		<category><![CDATA[VLTR]]></category>
		<category><![CDATA[Volterra Semiconductor Corporation]]></category>
		<category><![CDATA[VRSN]]></category>
		<category><![CDATA[VZ]]></category>
		<category><![CDATA[W.W. Grainger Inc]]></category>
		<category><![CDATA[WAL]]></category>
		<category><![CDATA[WAT]]></category>
		<category><![CDATA[Waters Corporation]]></category>
		<category><![CDATA[WCBO]]></category>
		<category><![CDATA[WDC]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[West BanCorporation Inc]]></category>
		<category><![CDATA[West Coast Bancorp]]></category>
		<category><![CDATA[Western Alliance Bancorporation]]></category>
		<category><![CDATA[Western Digital Corporation]]></category>
		<category><![CDATA[Weyerhaeuser Company]]></category>
		<category><![CDATA[WIBC]]></category>
		<category><![CDATA[Wilshire Bancorp Inc]]></category>
		<category><![CDATA[WLP]]></category>
		<category><![CDATA[WTBA]]></category>
		<category><![CDATA[WY]]></category>
		<category><![CDATA[Xerox Corporation]]></category>
		<category><![CDATA[XRX]]></category>
		<category><![CDATA[ZZ]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=126708</guid>
		<description><![CDATA[The fourth quarter reporting season gets into high gear this week, with 253 companies coming out with quarterly results, including 83 S&#38;P 500 companies. The earnings season thus far has been relatively uneventful, but we will have a better idea by the end of this week; by then we will have seen 30% of the total fourth quarter reports. While last week was all about banks, the focus this week is on the Technology sector, particularly Apple (AAPL) which reports after the close on Wednesday. The iPhone maker has lost some of its sizzle lately and is expected to see earnings decline from the same period last year. No company grows forever, but it may be premature to write Apple off. Other major Tech companies reporting results this week include ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2013/01/20/aapl-fourth-quarter-2012-earnings-season-gets-into-high-gear-earnings-preview/126708/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DGX) Quest Diagnostics Remains Neutral</title>
		<link>http://www.stockbloghub.com/2012/12/04/dgx-quest-diagnostics-remains-neutral/122819</link>
		<comments>http://www.stockbloghub.com/2012/12/04/dgx-quest-diagnostics-remains-neutral/122819#comments</comments>
		<pubDate>Wed, 05 Dec 2012 06:21:14 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Laboratories & Research]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[Laboratory Corporation of America Holdings]]></category>
		<category><![CDATA[LH]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=122819</guid>
		<description><![CDATA[We recently reiterated our Neutral recommendation on Quest Diagnostics (DGX), the leading providers of commercial laboratory services in North America, with a target price of $61.00. The company reported adjusted earnings per share (EPS) of $1.18 in the third quarter of 2012, flat year over year and in line with the Zacks Consensus Estimate. Revenues were down 2.9% year over year to $1.85 billion, nominally missing the Zacks Consensus Estimate of $1.88 billion. The overall soft industry trends leading to low volume growth was a dampener for the company. This low growth rate was primarily due to a challenging volume environment for testing laboratories and utilization weaknesses across the healthcare sector. Low level of employment and slow growth of commercially insured lives will continue to affect the company’s overall growth ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/12/04/dgx-quest-diagnostics-remains-neutral/122819/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DGX) Quest Diagnostics Disappoints in Third Quarter &#8211; Guides Low</title>
		<link>http://www.stockbloghub.com/2012/10/29/dgx-quest-diagnostics-disappoints-in-third-quarter-guides-low/116784</link>
		<comments>http://www.stockbloghub.com/2012/10/29/dgx-quest-diagnostics-disappoints-in-third-quarter-guides-low/116784#comments</comments>
		<pubDate>Mon, 29 Oct 2012 17:33:59 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Laboratories & Research]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[Laboratory Corporation of America Holdings]]></category>
		<category><![CDATA[LH]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=116784</guid>
		<description><![CDATA[Leading diagnostic testing company Quest Diagnostics (DGX) reported earnings per share (EPS) of $1.01 in the third quarter of 2012, down considerably from $1.08 in the year-ago period. However, after taking into account certain charges related to restructuring and integration (17 cents), adjusted EPS from continuing operations came in at $1.18, flat year over year and remained in line with the Zacks Consensus Estimate. The year-ago quarter recorded a cost of 10 cents per share related to restructuring and integration. Revenues for the quarter were down 2.9% year over year to $1.85 billion nominally missing the Zacks Consensus Estimate of $1.88 billion. Clinical testing revenues during the quarter decreased 2.1% and volume (measured by the number of requisitions) inched down 1.1%. Revenue per requisition was down 1% year over year. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/10/29/dgx-quest-diagnostics-disappoints-in-third-quarter-guides-low/116784/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ARE) Alexandria Real Estate Equities Pens New Lease Deals</title>
		<link>http://www.stockbloghub.com/2012/10/23/are-alexandria-real-estate-equities-pens-new-lease-deals/115769</link>
		<comments>http://www.stockbloghub.com/2012/10/23/are-alexandria-real-estate-equities-pens-new-lease-deals/115769#comments</comments>
		<pubDate>Tue, 23 Oct 2012 15:09:32 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Financial]]></category>
		<category><![CDATA[REIT - Industrial]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[Alexandria Real Estate Equities Inc]]></category>
		<category><![CDATA[ARE]]></category>
		<category><![CDATA[BIIB]]></category>
		<category><![CDATA[Biogen Idec Inc]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[Glaxosmithkline plc]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[Novartis AG]]></category>
		<category><![CDATA[NVS]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=115769</guid>
		<description><![CDATA[Pasadena, California-based real estate investment trust (REIT), Alexandria Real Estate Equities, Inc. (ARE), recently entered into long-term agreements with four prestigious companies. The agreements are intended to pre-lease a total of 162,000 square feet at a property &#8211; 400 Technology Square – located in Cambridge, Massachusetts. The 400 Technology square comprises of rentable space of around 194,776 square feet and is one of the seven facilities located at the company’s state-of-the-art laboratory/office park-like community known as Alexandria Technology Square. The acquired property is currently in the final stage of redevelopment, which is expected to be completed later this year. Upon completion, the total square footage of the campus will be increased by around 18,000 square feet. Alexandria Technology Square is located in the Kendall Square neighborhood of Cambridge and consists ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/10/23/are-alexandria-real-estate-equities-pens-new-lease-deals/115769/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DGX) Quest Diagnostics&#8217; Simplexa Passes FDA Test</title>
		<link>http://www.stockbloghub.com/2012/10/23/dgx-quest-diagnostics-simplexa-passes-fda-test/116095</link>
		<comments>http://www.stockbloghub.com/2012/10/23/dgx-quest-diagnostics-simplexa-passes-fda-test/116095#comments</comments>
		<pubDate>Tue, 23 Oct 2012 14:57:06 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Laboratories & Research]]></category>
		<category><![CDATA[3M Company]]></category>
		<category><![CDATA[CAH]]></category>
		<category><![CDATA[Cardinal Health Inc.]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[Laboratory Corporation of America Holdings]]></category>
		<category><![CDATA[LH]]></category>
		<category><![CDATA[MMM]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=116095</guid>
		<description><![CDATA[Quest Diagnostics (DGX), a prominent player in the field of diagnostic testing, recently received the U.S. Food and Drug Administration’s (“FDA”) 510(k) clearance for its Simplexa Flu A/B &#38; RSV Direct test, which was developed by the company’s Focus Diagnostics Laboratory and a global technology company 3M (MMM). Subsequently, Quest Diagnostic launched this test in the U.S. Earlier in 2011 this test received CE mark approval in Europe. As another addition to Focus Diagnostics’ array of Simplexa branded molecular tests, the new assay will operate on 3M’s Integrated Cycler technology for the qualitative detection and differentiation of RNA of influenza A and B viruses and respiratory syncytial virus (RSV), which are the common causes of respiratory illness. Being the first-of-its-kind moderate-complexity molecular test among the Simplexa product line, it received Clinical ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/10/23/dgx-quest-diagnostics-simplexa-passes-fda-test/116095/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(LH) Laboratory Corporation of America Holdings Prices Senior Notes</title>
		<link>http://www.stockbloghub.com/2012/08/30/lh-laboratory-corporation-of-america-holdings-prices-senior-notes/109717</link>
		<comments>http://www.stockbloghub.com/2012/08/30/lh-laboratory-corporation-of-america-holdings-prices-senior-notes/109717#comments</comments>
		<pubDate>Thu, 30 Aug 2012 16:28:12 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Laboratories & Research]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[Laboratory Corporation of America Holdings]]></category>
		<category><![CDATA[LH]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=109717</guid>
		<description><![CDATA[Laboratory Corporation of America Holdings (LH), has priced its senior notes to be used primarily to repay certain amounts outstanding under its existing credit facility (announced in December, 2011), for an aggregate purchase price of $1 billion. The company is issuing the notes in two installments – $500 million of 2.20% senior notes due 2017 and another $500 million of 3.75% senior notes due 2022. The issuance of the notes that will close on August 23, 2012, will pay semi-annual interest. Besides the repayment of dues under its credit facility, the company also intends to use the net proceeds of this offering for general corporate purposes. LabCorp is well capitalized and exited the second quarter with cash and short-term investments of $124.4 million ($159.3 million at the end of 2011) and ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/08/30/lh-laboratory-corporation-of-america-holdings-prices-senior-notes/109717/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(LH) Laboratory Corporation of America Holdings Earnings Scorecard</title>
		<link>http://www.stockbloghub.com/2012/07/31/lh-laboratory-corporation-of-america-holdings-earnings-scorecard-2/106296</link>
		<comments>http://www.stockbloghub.com/2012/07/31/lh-laboratory-corporation-of-america-holdings-earnings-scorecard-2/106296#comments</comments>
		<pubDate>Tue, 31 Jul 2012 17:30:03 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Laboratories & Research]]></category>
		<category><![CDATA[CI]]></category>
		<category><![CDATA[CIGNA Corporation]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[HUM]]></category>
		<category><![CDATA[Humana Inc.]]></category>
		<category><![CDATA[Laboratory Corporation of America Holdings]]></category>
		<category><![CDATA[LH]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=106296</guid>
		<description><![CDATA[Laboratory Corporation of America Holdings’ (LH) disappointing second quarter 2012 results, released on July 19, prompted analysts to slash their estimates for the forthcoming periods, pricing in the challenges currently at play in this sector. Second Quarter Highlights LabCorp reported earnings per share (“EPS”) of $1.56 in the second quarter of fiscal 2012 compared with $1.20 in the year-ago quarter. Restructuring charge aside, the company recorded expenses related to acquisitions and loss on the disposal of one of its European subsidiaries and one of its joint ventures. Adjusted EPS came in at $1.77 (excluding amortization, restructuring and other special charges), a penny behind the Zacks Consensus Estimate. Earnings, however, surpassed the previous year&#8217;s adjusted EPS of $1.64. Revenues increased 1.4% year over year to $1,423.4 million, marginally missing the Zacks ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/07/31/lh-laboratory-corporation-of-america-holdings-earnings-scorecard-2/106296/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(LH) Laboratory Corporation of America Holdings Earnings Preview</title>
		<link>http://www.stockbloghub.com/2012/07/23/lh-laboratory-corporation-of-america-holdings-earnings-preview/104871</link>
		<comments>http://www.stockbloghub.com/2012/07/23/lh-laboratory-corporation-of-america-holdings-earnings-preview/104871#comments</comments>
		<pubDate>Mon, 23 Jul 2012 17:39:43 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Laboratories & Research]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[EPS]]></category>
		<category><![CDATA[HUM]]></category>
		<category><![CDATA[Humana Inc.]]></category>
		<category><![CDATA[Laboratory Corporation of America Holdings]]></category>
		<category><![CDATA[LH]]></category>
		<category><![CDATA[MEDTOX Scientific Inc]]></category>
		<category><![CDATA[MTOX]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>
		<category><![CDATA[WisdomTree Earnings 500]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=104871</guid>
		<description><![CDATA[Laboratory Corporation of America Holdings (LH) is scheduled to release its second quarter fiscal 2012 earnings on Thursday, July 19, 2012, before the market opens. The company is expected to report earnings per share (EPS) of $1.78 on revenue of $1.44 billion for the quarter, according to the Zacks Consensus Estimates. Prior-Quarter Highlights LabCorp reported EPS of $1.63 in the first quarter of fiscal 2012 compared with $1.23 in the year-ago quarter. Adjusted EPS came in at $1.74 (excluding amortization, restructuring and other special charges), sailing past the Zacks Consensus Estimate of $1.68 and the previous year&#8217;s adjusted EPS of $1.52. Revenues increased 4% year over year to $1,423.3 million, ahead of the Zacks Consensus Estimate of $1,404 million. Testing volume (measured by requisitions) and revenue per requisition increased 2.8% ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/07/23/lh-laboratory-corporation-of-america-holdings-earnings-preview/104871/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(QGEN) Qiagen&#8217;s KRAS Test Earns U.S. Food and Drug Administration Nod</title>
		<link>http://www.stockbloghub.com/2012/07/09/qgen-qiagens-kras-test-earns-u-s-food-and-drug-administration-nod/104070</link>
		<comments>http://www.stockbloghub.com/2012/07/09/qgen-qiagens-kras-test-earns-u-s-food-and-drug-administration-nod/104070#comments</comments>
		<pubDate>Mon, 09 Jul 2012 16:08:02 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[BMY]]></category>
		<category><![CDATA[Bristol-Myers Squibb Company]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[Eli Lilly & Company]]></category>
		<category><![CDATA[Laboratory Corporation of America Holdings]]></category>
		<category><![CDATA[LH]]></category>
		<category><![CDATA[LLY]]></category>
		<category><![CDATA[MYGN]]></category>
		<category><![CDATA[Myriad Genetics Inc.]]></category>
		<category><![CDATA[QGEN]]></category>
		<category><![CDATA[Qiagen NV]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=104070</guid>
		<description><![CDATA[Molecular diagnostics solutions provider, Qiagen (QGEN) recently got the nod of the U.S. Food and Drug Administration (“FDA”) to market the therascreen KRAS RGQ PCR Kit (therascreen KRAS test), which helps in determining the responsiveness of the metastatic colorectal cancer patients to the drug Erbitux (cetuximab). Qiagen considers this FDA approval of the therascreen KRAS test as a major breakthrough in the company’s international expansion of its Personalized Healthcare franchise that comprises a huge portfolio of molecular companion diagnostics to guide treatments in oncology. The drug Erbitux is an epidermal growth factor receptor (EGFR) inhibitor and is used to treat colon and rectum cancer. It is also beneficial for head and neck cancer treatment. Currently, this drug is marketed in the U.S. by Bristol-Myers Squibb Co. (BMY) and Eli Lilly ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/07/09/qgen-qiagens-kras-test-earns-u-s-food-and-drug-administration-nod/104070/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ARE) Alexandria Real Estate Equities Sees New Lease Agreements</title>
		<link>http://www.stockbloghub.com/2012/06/10/are-alexandria-real-estate-equities-sees-new-lease-agreements/101717</link>
		<comments>http://www.stockbloghub.com/2012/06/10/are-alexandria-real-estate-equities-sees-new-lease-agreements/101717#comments</comments>
		<pubDate>Sun, 10 Jun 2012 19:01:24 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Financial]]></category>
		<category><![CDATA[REIT - Industrial]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[Alexandria Real Estate Equities Inc]]></category>
		<category><![CDATA[ARE]]></category>
		<category><![CDATA[BIIB]]></category>
		<category><![CDATA[Biogen Idec Inc]]></category>
		<category><![CDATA[CELG]]></category>
		<category><![CDATA[Celgene Corporation]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[Glaxosmithkline plc]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[LIFE]]></category>
		<category><![CDATA[Life Technologies Corporation]]></category>
		<category><![CDATA[Novartis AG]]></category>
		<category><![CDATA[NVS]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>
		<category><![CDATA[SNTA]]></category>
		<category><![CDATA[Synta Pharmaceuticals Corporation]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=101717</guid>
		<description><![CDATA[Alexandria Real Estate Equities, Inc. (ARE), a real estate investment trust (REIT), recently entered into long-term agreements with six prestigious life science and technologies companies, to lease a total of 187,000 square feet of space at ‘Alexandria Park at 128’ located in the midst of Route 128 sub-market of Greater Boston. Alexandria Park at 128 is an eight-building science and Technology Park, spanning approximately 345,000 square feet. Strategically located near Hartwell Avenue, the property is well connected to various residential areas, restaurants, shops, and convenient amenities. The property is already occupied by leading life science and advanced technology companies including TIAX LLC, RainDance Technologies, Inc., Diversified Technologies, Inc., Celgene Corp. (CELG) and Synta Pharmaceuticals Corp. (SNTA). After the agreement, the property will now have six more renowned firms as its ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/06/10/are-alexandria-real-estate-equities-sees-new-lease-agreements/101717/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(LH) Laboratory Corporation of America Holdings-Orchid Deal Evinces FTC Nod</title>
		<link>http://www.stockbloghub.com/2011/12/09/lh-laboratory-corporation-of-america-holdings-orchid-deal-evinces-ftc-nod/88339</link>
		<comments>http://www.stockbloghub.com/2011/12/09/lh-laboratory-corporation-of-america-holdings-orchid-deal-evinces-ftc-nod/88339#comments</comments>
		<pubDate>Fri, 09 Dec 2011 20:43:56 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Laboratories & Research]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[First Trust Large Cap Gr Opp AlphaDEX]]></category>
		<category><![CDATA[FTC]]></category>
		<category><![CDATA[Laboratory Corporation of America Holdings]]></category>
		<category><![CDATA[LH]]></category>
		<category><![CDATA[ORCH]]></category>
		<category><![CDATA[Orchid Cellmark Inc.]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=88339</guid>
		<description><![CDATA[Laboratory Corporation of America Holdings (LH) received the much awaited nod from the US Federal Trade Commission (FTC) for the proposed acquisition of Orchid Cellmark (ORCH). The FTC nod comes with the rider that LabCorp will have to hive off certain assets of Orchid’s US government paternity business following completion of the transaction. This would reduce the “anti-competitive impact” of the proposed merger, according to the federal agency. LabCorp has agreed to sell those assets to DNA Diagnostics Center, an Ohio based privately held provider of DNA paternity testing. The pending issue with FTC dates back to May 2011. The company’s tender offer for Orchid is scheduled to expire today, unless extended further. LabCorp had decided in April 2011 to acquire Orchid for $2.80 per share, coming to a total ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/12/09/lh-laboratory-corporation-of-america-holdings-orchid-deal-evinces-ftc-nod/88339/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(LH) Laboratory Corporation of America Holdings Extends Orchid Bid Again</title>
		<link>http://www.stockbloghub.com/2011/12/07/lh-laboratory-corporation-of-america-holdings-extends-orchid-bid-again/88036</link>
		<comments>http://www.stockbloghub.com/2011/12/07/lh-laboratory-corporation-of-america-holdings-extends-orchid-bid-again/88036#comments</comments>
		<pubDate>Wed, 07 Dec 2011 17:53:29 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Laboratories & Research]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[First Trust Large Cap Gr Opp AlphaDEX]]></category>
		<category><![CDATA[FTC]]></category>
		<category><![CDATA[Laboratory Corporation of America Holdings]]></category>
		<category><![CDATA[LH]]></category>
		<category><![CDATA[ORCH]]></category>
		<category><![CDATA[Orchid Cellmark Inc.]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=88036</guid>
		<description><![CDATA[Laboratory Corporation of America Holdings (LH) has once again extended the tender offer for Orchid Cellmark (ORCH) until December 9, 2011. The company had earlier extended the tender offer to November 30. In May 2011, the company received a request from the Federal Trade Commission (FTC) for some additional information related to the transaction. LabCorp is cooperating with the FTC on this issue. To date, about 88.2% of the outstanding shares of Orchid have been tendered. LabCorp had decided in April 2011 to acquire Orchid Cellmark for $2.80 per share, coming to a total consideration of $85.4 million, all in cash. After taking into account Orchid Cellmark’s cash balance, LabCorp’s net payable comes to $65.6 million. Orchid Cellmark provides DNA testing services targeted towards forensic and family relationship applications on ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/12/07/lh-laboratory-corporation-of-america-holdings-extends-orchid-bid-again/88036/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DGX) The Future of Healthcare &#8211; Personalized Medicine</title>
		<link>http://www.stockbloghub.com/2011/11/10/dgx-the-future-of-healthcare-personalized-medicine/86765</link>
		<comments>http://www.stockbloghub.com/2011/11/10/dgx-the-future-of-healthcare-personalized-medicine/86765#comments</comments>
		<pubDate>Thu, 10 Nov 2011 17:54:49 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Laboratories & Research]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[Laboratory Corporation of America Holdings]]></category>
		<category><![CDATA[LH]]></category>
		<category><![CDATA[LULU]]></category>
		<category><![CDATA[Lululemon Athletica Inc]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>
		<category><![CDATA[UNFI]]></category>
		<category><![CDATA[United Natural Foods Inc.]]></category>
		<category><![CDATA[WFMI]]></category>
		<category><![CDATA[Whole Foods Market Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=86765</guid>
		<description><![CDATA[by Marc Lichtenfeld, Investment U Senior Analyst Wednesday, November 9, 2011: Issue #1639 I just got back from my annual physical. Fortunately, everything was fine. But my experience solidified my belief that one of the major healthcare trends that will emerge is the concept of personalized medicine. I had been going to the same doctor every year since 2003. He’s a good guy and has helped me when I’ve been sick. But when I went for my physical every year, he’d tell me to watch my cholesterol, turn my head and cough, and that was pretty much the end of it. This year, I changed doctors. The practice I go to takes a more holistic approach. No, they’re not burning incense and the place doesn’t smell like patchouli. They’re still ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/10/dgx-the-future-of-healthcare-personalized-medicine/86765/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(LH) Laboratory Corporation of America Holdings Earnings Scorecard</title>
		<link>http://www.stockbloghub.com/2011/11/03/lh-laboratory-corporation-of-america-holdings-earnings-scorecard/86241</link>
		<comments>http://www.stockbloghub.com/2011/11/03/lh-laboratory-corporation-of-america-holdings-earnings-scorecard/86241#comments</comments>
		<pubDate>Thu, 03 Nov 2011 15:12:33 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Laboratories & Research]]></category>
		<category><![CDATA[CI]]></category>
		<category><![CDATA[CIGNA Corporation]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[HUM]]></category>
		<category><![CDATA[Humana Inc.]]></category>
		<category><![CDATA[Laboratory Corporation of America Holdings]]></category>
		<category><![CDATA[LH]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=86241</guid>
		<description><![CDATA[The announcement of Laboratory Corporation of America Holdings’ (LH) third quarter fiscal 2011 results, as on October 20, 2011, has led analysts to revise their estimates lower for the fourth quarter and fiscal 2011. Third Quarter Highlights LabCorp reported adjusted EPS of $1.61 (excluding amortization, restructuring and other special charges) for the third quarter of fiscal 2011. The result was higher than the Zacks Consensus Estimate of $1.60 and the previous year&#8217;s adjusted EPS of $1.58. Revenues increased 10% year over year to $1,404.5 million, marginally missing the Zacks Consensus Estimate of $1,408 million. Testing volume (measured by requisitions) and revenue per requisition increased 2.1% and 7.8%, respectively. LabCorp updated its guidance for fiscal 2011. The company now expects a 10.5?11% revenue growth (previous guidance of 9.5?11.5%) resulting in adjusted EPS ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/03/lh-laboratory-corporation-of-america-holdings-earnings-scorecard/86241/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AAPL) 2011 Second Quarter Earnings Preview &#8211; Detailed</title>
		<link>http://www.stockbloghub.com/2011/07/18/aapl-2011-second-quarter-earnings-preview-detailed/79251</link>
		<comments>http://www.stockbloghub.com/2011/07/18/aapl-2011-second-quarter-earnings-preview-detailed/79251#comments</comments>
		<pubDate>Mon, 18 Jul 2011 21:09:50 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Personal Computers]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[8x8 Inc]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[ABB]]></category>
		<category><![CDATA[ABB Limited]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[Acacia Research Corporation]]></category>
		<category><![CDATA[Acme Packet Inc]]></category>
		<category><![CDATA[ACTG]]></category>
		<category><![CDATA[ADS]]></category>
		<category><![CDATA[Advanced Micro Devices Inc.]]></category>
		<category><![CDATA[AF]]></category>
		<category><![CDATA[Air Products & Chemicals Inc.]]></category>
		<category><![CDATA[Alaska Air Group Inc.]]></category>
		<category><![CDATA[ALB]]></category>
		<category><![CDATA[Albemarle Corporation]]></category>
		<category><![CDATA[Alexion Pharmaceuticals Inc]]></category>
		<category><![CDATA[ALK]]></category>
		<category><![CDATA[Alliance Data Systems Corporation]]></category>
		<category><![CDATA[Altera Corporation]]></category>
		<category><![CDATA[ALTR]]></category>
		<category><![CDATA[Altria Group Inc.]]></category>
		<category><![CDATA[ALV]]></category>
		<category><![CDATA[ALXN]]></category>
		<category><![CDATA[AMD]]></category>
		<category><![CDATA[American Express Company]]></category>
		<category><![CDATA[AmeriServ Financial Inc]]></category>
		<category><![CDATA[Amphenol Corporation]]></category>
		<category><![CDATA[AMR]]></category>
		<category><![CDATA[AMR Corporation]]></category>
		<category><![CDATA[AMSG]]></category>
		<category><![CDATA[AmSurg Corporation]]></category>
		<category><![CDATA[AMTD]]></category>
		<category><![CDATA[AO Smith Corporation]]></category>
		<category><![CDATA[AOS]]></category>
		<category><![CDATA[APD]]></category>
		<category><![CDATA[APH]]></category>
		<category><![CDATA[APKT]]></category>
		<category><![CDATA[Apple Inc.]]></category>
		<category><![CDATA[AptarGroup Inc.]]></category>
		<category><![CDATA[ARB]]></category>
		<category><![CDATA[Arbitron Inc]]></category>
		<category><![CDATA[ASBC]]></category>
		<category><![CDATA[ASR]]></category>
		<category><![CDATA[ASRV]]></category>
		<category><![CDATA[Associated Banc-Corp]]></category>
		<category><![CDATA[Astoria Financial Corporation]]></category>
		<category><![CDATA[AT Cross Company]]></category>
		<category><![CDATA[AT&T Inc.]]></category>
		<category><![CDATA[Athenahealth Inc]]></category>
		<category><![CDATA[ATHN]]></category>
		<category><![CDATA[ATMI]]></category>
		<category><![CDATA[ATMI Inc.]]></category>
		<category><![CDATA[ATR]]></category>
		<category><![CDATA[ATX]]></category>
		<category><![CDATA[Autoliv Inc.]]></category>
		<category><![CDATA[AVID]]></category>
		<category><![CDATA[Avid Technology Inc]]></category>
		<category><![CDATA[AXP]]></category>
		<category><![CDATA[BAC]]></category>
		<category><![CDATA[Badger Meter Inc]]></category>
		<category><![CDATA[BancFirst Corporation]]></category>
		<category><![CDATA[Banco Latinoamericano de Exportaciones SA]]></category>
		<category><![CDATA[Bancorp Rhode Island Inc]]></category>
		<category><![CDATA[BANF]]></category>
		<category><![CDATA[Bank of America Corporation]]></category>
		<category><![CDATA[Banner Corporation]]></category>
		<category><![CDATA[BANR]]></category>
		<category><![CDATA[BARI]]></category>
		<category><![CDATA[BAS]]></category>
		<category><![CDATA[Basic Energy Services Inc.]]></category>
		<category><![CDATA[BAX]]></category>
		<category><![CDATA[Baxter International Inc]]></category>
		<category><![CDATA[BB & T Corporation]]></category>
		<category><![CDATA[BBT]]></category>
		<category><![CDATA[BJ's Restaurants Inc.]]></category>
		<category><![CDATA[BJRI]]></category>
		<category><![CDATA[BK]]></category>
		<category><![CDATA[BlackRock Inc.]]></category>
		<category><![CDATA[BLDR]]></category>
		<category><![CDATA[BLK]]></category>
		<category><![CDATA[BLX]]></category>
		<category><![CDATA[BMI]]></category>
		<category><![CDATA[BOOT]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BPOP]]></category>
		<category><![CDATA[BRO]]></category>
		<category><![CDATA[Brown & Brown Inc.]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[BTU]]></category>
		<category><![CDATA[Builders FirstSource Inc]]></category>
		<category><![CDATA[BX]]></category>
		<category><![CDATA[CA]]></category>
		<category><![CDATA[Ca Technologies]]></category>
		<category><![CDATA[CAKE]]></category>
		<category><![CDATA[Cardinal Financial Corporation]]></category>
		<category><![CDATA[Cash America International Inc]]></category>
		<category><![CDATA[CAT]]></category>
		<category><![CDATA[Caterpillar Inc.]]></category>
		<category><![CDATA[Cathay General Bancorp]]></category>
		<category><![CDATA[CATY]]></category>
		<category><![CDATA[CB]]></category>
		<category><![CDATA[CBE]]></category>
		<category><![CDATA[CBI]]></category>
		<category><![CDATA[CCK]]></category>
		<category><![CDATA[CE]]></category>
		<category><![CDATA[Celanese Corporation]]></category>
		<category><![CDATA[Celestica Inc.]]></category>
		<category><![CDATA[Cemex S.A.B. de C.V.]]></category>
		<category><![CDATA[Central Valley Community Bancorp]]></category>
		<category><![CDATA[Cepheid]]></category>
		<category><![CDATA[CFNL]]></category>
		<category><![CDATA[Charles Schwab Corporation]]></category>
		<category><![CDATA[Check Point Software Technologies Limited]]></category>
		<category><![CDATA[Chicago Bridge & Iron Company N.V.]]></category>
		<category><![CDATA[Chipotle Mexican Grill Inc.]]></category>
		<category><![CDATA[CHKP]]></category>
		<category><![CDATA[Cintas Corporation]]></category>
		<category><![CDATA[Cirrus Logic Inc.]]></category>
		<category><![CDATA[City National Corporation]]></category>
		<category><![CDATA[CLB]]></category>
		<category><![CDATA[CLS]]></category>
		<category><![CDATA[CMA]]></category>
		<category><![CDATA[CMCO]]></category>
		<category><![CDATA[CMG]]></category>
		<category><![CDATA[CNS]]></category>
		<category><![CDATA[CoBiz Financial Inc]]></category>
		<category><![CDATA[COBZ]]></category>
		<category><![CDATA[Coca-Cola FEMSA S.A.B de CV]]></category>
		<category><![CDATA[Cohen & Steers Inc.]]></category>
		<category><![CDATA[COHU]]></category>
		<category><![CDATA[Cohu Inc]]></category>
		<category><![CDATA[COL]]></category>
		<category><![CDATA[Columbus Mckinnon Corporation]]></category>
		<category><![CDATA[Comerica Incorporated]]></category>
		<category><![CDATA[Complete Production Services Inc]]></category>
		<category><![CDATA[Compuware Corporation]]></category>
		<category><![CDATA[Cooper Industries Limited]]></category>
		<category><![CDATA[Core Laboratories NV]]></category>
		<category><![CDATA[Covanta Holding Corporation]]></category>
		<category><![CDATA[CPHD]]></category>
		<category><![CDATA[CPWR]]></category>
		<category><![CDATA[CPX]]></category>
		<category><![CDATA[Crown Holdings Inc.]]></category>
		<category><![CDATA[CRUS]]></category>
		<category><![CDATA[CSH]]></category>
		<category><![CDATA[CSX]]></category>
		<category><![CDATA[CSX Corporation]]></category>
		<category><![CDATA[CTAS]]></category>
		<category><![CDATA[CVA]]></category>
		<category><![CDATA[CVB Financial Corporation]]></category>
		<category><![CDATA[CVBF]]></category>
		<category><![CDATA[CVCY]]></category>
		<category><![CDATA[CX]]></category>
		<category><![CDATA[CY]]></category>
		<category><![CDATA[Cymer Inc.]]></category>
		<category><![CDATA[CYMI]]></category>
		<category><![CDATA[CYN]]></category>
		<category><![CDATA[Cypress Semiconductor Corporation]]></category>
		<category><![CDATA[CYT]]></category>
		<category><![CDATA[Cytec Industries Inc.]]></category>
		<category><![CDATA[DAL]]></category>
		<category><![CDATA[Danaher Corporation]]></category>
		<category><![CDATA[Datalink Corporation]]></category>
		<category><![CDATA[Delta Air Lines Inc.]]></category>
		<category><![CDATA[DGII]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[DHR]]></category>
		<category><![CDATA[Diamond Offshore Drilling Inc]]></category>
		<category><![CDATA[Digi International Inc.]]></category>
		<category><![CDATA[DO]]></category>
		<category><![CDATA[DOV]]></category>
		<category><![CDATA[Dover Corporation]]></category>
		<category><![CDATA[DTLK]]></category>
		<category><![CDATA[E*TRADE Financial Corporation]]></category>
		<category><![CDATA[Eagle Bancorp Inc]]></category>
		<category><![CDATA[East West Bancorp Inc]]></category>
		<category><![CDATA[Eastern Virginia Bankshares Inc]]></category>
		<category><![CDATA[EastGroup Properties Inc]]></category>
		<category><![CDATA[EBAY]]></category>
		<category><![CDATA[eBay Inc.]]></category>
		<category><![CDATA[ECA]]></category>
		<category><![CDATA[EDR]]></category>
		<category><![CDATA[EDU]]></category>
		<category><![CDATA[Education Realty Trust Inc]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EFII]]></category>
		<category><![CDATA[EGBN]]></category>
		<category><![CDATA[EGHT]]></category>
		<category><![CDATA[EGP]]></category>
		<category><![CDATA[Electronics for Imaging Inc.]]></category>
		<category><![CDATA[ELGX]]></category>
		<category><![CDATA[Eli Lilly & Company]]></category>
		<category><![CDATA[ELS]]></category>
		<category><![CDATA[EMC]]></category>
		<category><![CDATA[EMC Corporation]]></category>
		<category><![CDATA[Encana Corporation]]></category>
		<category><![CDATA[Endologix Inc]]></category>
		<category><![CDATA[Entegris Inc]]></category>
		<category><![CDATA[ENTG]]></category>
		<category><![CDATA[Equity Lifestyles Properties Inc]]></category>
		<category><![CDATA[ERIC]]></category>
		<category><![CDATA[ESI]]></category>
		<category><![CDATA[ETFC]]></category>
		<category><![CDATA[EVBS]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[EWBC]]></category>
		<category><![CDATA[EXPO]]></category>
		<category><![CDATA[Exponent Inc.]]></category>
		<category><![CDATA[EZCORP Inc.]]></category>
		<category><![CDATA[EZPW]]></category>
		<category><![CDATA[F5 Networks Inc.]]></category>
		<category><![CDATA[FCFS]]></category>
		<category><![CDATA[FCX]]></category>
		<category><![CDATA[FFIV]]></category>
		<category><![CDATA[Fidelity National Information Services Inc]]></category>
		<category><![CDATA[Fifth Third Bancorp]]></category>
		<category><![CDATA[First Cash Financial Services Inc]]></category>
		<category><![CDATA[First Niagara Financial Group Inc]]></category>
		<category><![CDATA[FIS]]></category>
		<category><![CDATA[FITB]]></category>
		<category><![CDATA[FLEX]]></category>
		<category><![CDATA[Flextronics International Limited]]></category>
		<category><![CDATA[FLIR]]></category>
		<category><![CDATA[FLIR Systems Inc]]></category>
		<category><![CDATA[FMX]]></category>
		<category><![CDATA[FNFG]]></category>
		<category><![CDATA[Fomento Economico Mexicano S.a.b De C.v.]]></category>
		<category><![CDATA[Forest Laboratories Inc.]]></category>
		<category><![CDATA[Forward Air Corporation]]></category>
		<category><![CDATA[Freeport-McMoRan Copper & Gold Inc]]></category>
		<category><![CDATA[FRX]]></category>
		<category><![CDATA[FULT]]></category>
		<category><![CDATA[Fulton Financial Corporation]]></category>
		<category><![CDATA[FWRD]]></category>
		<category><![CDATA[Gannett Company Inc]]></category>
		<category><![CDATA[Gardner Denver Inc.]]></category>
		<category><![CDATA[GCI]]></category>
		<category><![CDATA[GDI]]></category>
		<category><![CDATA[GE]]></category>
		<category><![CDATA[General Electric Company]]></category>
		<category><![CDATA[Gentex Corporation]]></category>
		<category><![CDATA[GLF]]></category>
		<category><![CDATA[Glimcher Realty Trust]]></category>
		<category><![CDATA[Global Payments Inc]]></category>
		<category><![CDATA[GNTX]]></category>
		<category><![CDATA[Goldman Sachs Group]]></category>
		<category><![CDATA[Goodrich Corporation]]></category>
		<category><![CDATA[GPN]]></category>
		<category><![CDATA[GR]]></category>
		<category><![CDATA[GRT]]></category>
		<category><![CDATA[Grupo Aeroportuario Centro Norte S.A. de C.V.]]></category>
		<category><![CDATA[Grupo Aeroportuario Del Sureste SA de CV]]></category>
		<category><![CDATA[GS]]></category>
		<category><![CDATA[Gulfmark Offshore Inc.]]></category>
		<category><![CDATA[GWW]]></category>
		<category><![CDATA[HAFC]]></category>
		<category><![CDATA[HAL]]></category>
		<category><![CDATA[Halliburton Company]]></category>
		<category><![CDATA[Hancock Holding Company]]></category>
		<category><![CDATA[Hanesbrands Inc.]]></category>
		<category><![CDATA[Hanmi Financial Corporation]]></category>
		<category><![CDATA[Harley-Davidson Inc.]]></category>
		<category><![CDATA[HAS]]></category>
		<category><![CDATA[Hasbro Inc.]]></category>
		<category><![CDATA[HBAN]]></category>
		<category><![CDATA[HBHC]]></category>
		<category><![CDATA[HBI]]></category>
		<category><![CDATA[Healthways Inc]]></category>
		<category><![CDATA[Heartland Express Inc]]></category>
		<category><![CDATA[HGSI]]></category>
		<category><![CDATA[HITT]]></category>
		<category><![CDATA[Hittite Microwave Corporation]]></category>
		<category><![CDATA[HNI]]></category>
		<category><![CDATA[HNI Corporation]]></category>
		<category><![CDATA[HOG]]></category>
		<category><![CDATA[HOMB]]></category>
		<category><![CDATA[Home Bancshares Inc (Conway AR)]]></category>
		<category><![CDATA[HON]]></category>
		<category><![CDATA[Honeywell International Inc.]]></category>
		<category><![CDATA[Host Hotels & Resorts Inc.]]></category>
		<category><![CDATA[HST]]></category>
		<category><![CDATA[HTLD]]></category>
		<category><![CDATA[Human Genome Sciences Inc.]]></category>
		<category><![CDATA[Huntington Bancshares Inc]]></category>
		<category><![CDATA[HWAY]]></category>
		<category><![CDATA[IBKR]]></category>
		<category><![CDATA[IBM]]></category>
		<category><![CDATA[ICLR]]></category>
		<category><![CDATA[ICON plc]]></category>
		<category><![CDATA[ICU Medical Inc]]></category>
		<category><![CDATA[ICUI]]></category>
		<category><![CDATA[IDEX Corporation]]></category>
		<category><![CDATA[IDEXX Laboratories Inc.]]></category>
		<category><![CDATA[IDXX]]></category>
		<category><![CDATA[IEX]]></category>
		<category><![CDATA[IIIN]]></category>
		<category><![CDATA[INFA]]></category>
		<category><![CDATA[Infinera Corporation]]></category>
		<category><![CDATA[INFN]]></category>
		<category><![CDATA[Informatica Corporation]]></category>
		<category><![CDATA[Ingersoll-Rand Company Limited]]></category>
		<category><![CDATA[Insteel Industries Inc.]]></category>
		<category><![CDATA[INTC]]></category>
		<category><![CDATA[Intel Corporation]]></category>
		<category><![CDATA[Interactive Brokers Group Inc]]></category>
		<category><![CDATA[International Business Machines]]></category>
		<category><![CDATA[Intuitive Surgical Inc]]></category>
		<category><![CDATA[IR]]></category>
		<category><![CDATA[ISRG]]></category>
		<category><![CDATA[ITT Educational Services Inc.]]></category>
		<category><![CDATA[Ixia]]></category>
		<category><![CDATA[JAKK]]></category>
		<category><![CDATA[JAKKS Pacific Inc.]]></category>
		<category><![CDATA[Janus Capital Group Inc.]]></category>
		<category><![CDATA[JCI]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[JNS]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Johnson Controls Inc.]]></category>
		<category><![CDATA[Kansas City Southern]]></category>
		<category><![CDATA[Kayne Anderson Energy Development Company]]></category>
		<category><![CDATA[KED]]></category>
		<category><![CDATA[KEY]]></category>
		<category><![CDATA[KeyCorp]]></category>
		<category><![CDATA[Kinder Morgan Energy Partners LP]]></category>
		<category><![CDATA[Kinder Morgan Management LLC]]></category>
		<category><![CDATA[KMP]]></category>
		<category><![CDATA[KMR]]></category>
		<category><![CDATA[KNL]]></category>
		<category><![CDATA[Knoll Inc.]]></category>
		<category><![CDATA[KO]]></category>
		<category><![CDATA[KOF]]></category>
		<category><![CDATA[KSU]]></category>
		<category><![CDATA[Laboratory Corporation of America Holdings]]></category>
		<category><![CDATA[Lacrosse Footwear Inc.]]></category>
		<category><![CDATA[Landstar System Inc.]]></category>
		<category><![CDATA[Lare Holdings Inc]]></category>
		<category><![CDATA[LaSalle Hotel Properties]]></category>
		<category><![CDATA[Lattice Semiconductor Corporation]]></category>
		<category><![CDATA[LCC]]></category>
		<category><![CDATA[LECO]]></category>
		<category><![CDATA[LH]]></category>
		<category><![CDATA[LHO]]></category>
		<category><![CDATA[Life Time Fitness Inc.]]></category>
		<category><![CDATA[Lincoln Electric Holdings]]></category>
		<category><![CDATA[LLY]]></category>
		<category><![CDATA[Lm Ericsson Telephone Company]]></category>
		<category><![CDATA[LNCR]]></category>
		<category><![CDATA[LSCC]]></category>
		<category><![CDATA[LSTR]]></category>
		<category><![CDATA[LTM]]></category>
		<category><![CDATA[LUFK]]></category>
		<category><![CDATA[Lufkin Industries Inc.]]></category>
		<category><![CDATA[M&T Bank Corporation]]></category>
		<category><![CDATA[MAN]]></category>
		<category><![CDATA[MANH]]></category>
		<category><![CDATA[Manhattan Associates Inc.]]></category>
		<category><![CDATA[Manpower Inc.]]></category>
		<category><![CDATA[Marten Transport Limited]]></category>
		<category><![CDATA[Matthews International Corporation]]></category>
		<category><![CDATA[MATW]]></category>
		<category><![CDATA[Mb Financial Inc]]></category>
		<category><![CDATA[MBFI]]></category>
		<category><![CDATA[MBWM]]></category>
		<category><![CDATA[MCBI]]></category>
		<category><![CDATA[MCD]]></category>
		<category><![CDATA[McDonald's Corporation]]></category>
		<category><![CDATA[McMoRan Exploration Company]]></category>
		<category><![CDATA[MCRI]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[Mellanox Technologies Limited]]></category>
		<category><![CDATA[Mercantile Bank Corporation]]></category>
		<category><![CDATA[Meridian Bioscience Inc.]]></category>
		<category><![CDATA[Merit Medical Systems Inc]]></category>
		<category><![CDATA[Metrocorp Bancshares Inc.]]></category>
		<category><![CDATA[MGIC Investment Corporation]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Microsoft Corporation]]></category>
		<category><![CDATA[MKS Instruments Inc.]]></category>
		<category><![CDATA[MKSI]]></category>
		<category><![CDATA[MLNX]]></category>
		<category><![CDATA[MMR]]></category>
		<category><![CDATA[MMSI]]></category>
		<category><![CDATA[MNRO]]></category>
		<category><![CDATA[MO]]></category>
		<category><![CDATA[MOH]]></category>
		<category><![CDATA[Molina Healthcare Inc.]]></category>
		<category><![CDATA[Monarch Casino & Resort Inc.]]></category>
		<category><![CDATA[Monro Muffler Brake Inc.]]></category>
		<category><![CDATA[Morgan Stanley]]></category>
		<category><![CDATA[MOS]]></category>
		<category><![CDATA[Mosaic Company]]></category>
		<category><![CDATA[MOSY]]></category>
		<category><![CDATA[MoSys Inc]]></category>
		<category><![CDATA[MRTN]]></category>
		<category><![CDATA[MS]]></category>
		<category><![CDATA[MSFT]]></category>
		<category><![CDATA[MTB]]></category>
		<category><![CDATA[MTG]]></category>
		<category><![CDATA[MYE]]></category>
		<category><![CDATA[Myers Industries Inc.]]></category>
		<category><![CDATA[NAFC]]></category>
		<category><![CDATA[Nash FInch Company]]></category>
		<category><![CDATA[NCR]]></category>
		<category><![CDATA[NCR Corporation]]></category>
		<category><![CDATA[NE]]></category>
		<category><![CDATA[NetScout Systems Inc]]></category>
		<category><![CDATA[New Oriental Education & Technology Group]]></category>
		<category><![CDATA[New York Community Bancorp Inc]]></category>
		<category><![CDATA[Newfield Exploration Company]]></category>
		<category><![CDATA[NFX]]></category>
		<category><![CDATA[Noble Corporation]]></category>
		<category><![CDATA[NOK]]></category>
		<category><![CDATA[Nokia Corporation]]></category>
		<category><![CDATA[Northern Trust Corporation]]></category>
		<category><![CDATA[Novartis AG]]></category>
		<category><![CDATA[NTCT]]></category>
		<category><![CDATA[NTRS]]></category>
		<category><![CDATA[Nucor Corporation]]></category>
		<category><![CDATA[NUE]]></category>
		<category><![CDATA[NVE Corporation]]></category>
		<category><![CDATA[NVEC]]></category>
		<category><![CDATA[NVR]]></category>
		<category><![CDATA[NVR Inc.]]></category>
		<category><![CDATA[NVS]]></category>
		<category><![CDATA[NYB]]></category>
		<category><![CDATA[NYT]]></category>
		<category><![CDATA[OceanFirst Financial Corporation]]></category>
		<category><![CDATA[OCFC]]></category>
		<category><![CDATA[OFG]]></category>
		<category><![CDATA[Old Republic International Corporation]]></category>
		<category><![CDATA[Olin Corporation]]></category>
		<category><![CDATA[OLN]]></category>
		<category><![CDATA[OMAB]]></category>
		<category><![CDATA[OMC]]></category>
		<category><![CDATA[Omnicom Group Inc.]]></category>
		<category><![CDATA[ORI]]></category>
		<category><![CDATA[Oriental Financial Group Inc.]]></category>
		<category><![CDATA[Pacific Continental Corporation]]></category>
		<category><![CDATA[Packaging Corporation of America]]></category>
		<category><![CDATA[PAG]]></category>
		<category><![CDATA[Park National Corporation]]></category>
		<category><![CDATA[PBCT]]></category>
		<category><![CDATA[PCBK]]></category>
		<category><![CDATA[PCP]]></category>
		<category><![CDATA[PDS]]></category>
		<category><![CDATA[Peabody Energy Corporation]]></category>
		<category><![CDATA[PENN]]></category>
		<category><![CDATA[Penn National Gaming Inc.]]></category>
		<category><![CDATA[Penske Automotive Group Inc.]]></category>
		<category><![CDATA[Peoples United Financial Inc]]></category>
		<category><![CDATA[PEP]]></category>
		<category><![CDATA[Pepsico Inc.]]></category>
		<category><![CDATA[PetMed Express Inc.]]></category>
		<category><![CDATA[PETS]]></category>
		<category><![CDATA[PGI]]></category>
		<category><![CDATA[Philip Morris International Inc]]></category>
		<category><![CDATA[PII]]></category>
		<category><![CDATA[Pinnacle Financial Partners Inc]]></category>
		<category><![CDATA[Piper Jaffray Companies]]></category>
		<category><![CDATA[PJC]]></category>
		<category><![CDATA[PKG]]></category>
		<category><![CDATA[Platinum Underwriters Holdings Limited]]></category>
		<category><![CDATA[PLCM]]></category>
		<category><![CDATA[Plexus Corporation]]></category>
		<category><![CDATA[PLXS]]></category>
		<category><![CDATA[PM]]></category>
		<category><![CDATA[PMC-Sierra Inc.]]></category>
		<category><![CDATA[PMCS]]></category>
		<category><![CDATA[PNC]]></category>
		<category><![CDATA[PNC Financial Services Group Inc]]></category>
		<category><![CDATA[PNFP]]></category>
		<category><![CDATA[Polaris Industries Inc.]]></category>
		<category><![CDATA[Polycom Inc.]]></category>
		<category><![CDATA[POOL]]></category>
		<category><![CDATA[Pool Corp]]></category>
		<category><![CDATA[Popular Inc]]></category>
		<category><![CDATA[PPG]]></category>
		<category><![CDATA[PPG Industries Inc.]]></category>
		<category><![CDATA[Precision Castparts Corporation]]></category>
		<category><![CDATA[Precision Drilling Trust]]></category>
		<category><![CDATA[Premiere Global Services Inc.]]></category>
		<category><![CDATA[PRK]]></category>
		<category><![CDATA[Prosperity Bancshares Inc.]]></category>
		<category><![CDATA[PRSP]]></category>
		<category><![CDATA[PTP]]></category>
		<category><![CDATA[QCOM]]></category>
		<category><![CDATA[QUALCOMM Inc]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>
		<category><![CDATA[RAI]]></category>
		<category><![CDATA[Raymond James Financial Inc.]]></category>
		<category><![CDATA[Renaissance Learning Inc.]]></category>
		<category><![CDATA[Renasant Corporation]]></category>
		<category><![CDATA[Reynolds American Inc.]]></category>
		<category><![CDATA[RHI]]></category>
		<category><![CDATA[Riverbed Technology Inc.]]></category>
		<category><![CDATA[RJF]]></category>
		<category><![CDATA[RLI]]></category>
		<category><![CDATA[RLI Corporation]]></category>
		<category><![CDATA[RLRN]]></category>
		<category><![CDATA[RNST]]></category>
		<category><![CDATA[Robert Half International Inc.]]></category>
		<category><![CDATA[Rockwell Collins Inc.]]></category>
		<category><![CDATA[RRR]]></category>
		<category><![CDATA[RSC Holdings Inc.]]></category>
		<category><![CDATA[RT]]></category>
		<category><![CDATA[Ruby Tuesday Inc.]]></category>
		<category><![CDATA[RVBD]]></category>
		<category><![CDATA[SABA]]></category>
		<category><![CDATA[Saba Software Inc.]]></category>
		<category><![CDATA[Safeway Inc.]]></category>
		<category><![CDATA[SanDisk Corporation]]></category>
		<category><![CDATA[Sandy Spring Bancorp Inc]]></category>
		<category><![CDATA[SASR]]></category>
		<category><![CDATA[SBIB]]></category>
		<category><![CDATA[Schiff Nutrition International Inc]]></category>
		<category><![CDATA[SCHL]]></category>
		<category><![CDATA[Schlumberger Limited]]></category>
		<category><![CDATA[Scholastic Corporation]]></category>
		<category><![CDATA[SCHW]]></category>
		<category><![CDATA[SCSS]]></category>
		<category><![CDATA[Seagate Technology]]></category>
		<category><![CDATA[SEI Investments Company]]></category>
		<category><![CDATA[SEIC]]></category>
		<category><![CDATA[Select Comfort Corporation]]></category>
		<category><![CDATA[Sensient Technologies Corporation]]></category>
		<category><![CDATA[SFG]]></category>
		<category><![CDATA[SFNC]]></category>
		<category><![CDATA[Sherwin-Williams Company]]></category>
		<category><![CDATA[SHW]]></category>
		<category><![CDATA[Simmons First National Corporation]]></category>
		<category><![CDATA[Skyworks Solutions Inc.]]></category>
		<category><![CDATA[SLB]]></category>
		<category><![CDATA[SLM]]></category>
		<category><![CDATA[Slm Corporation]]></category>
		<category><![CDATA[SNA]]></category>
		<category><![CDATA[Snap-on Inc.]]></category>
		<category><![CDATA[SNDK]]></category>
		<category><![CDATA[SON]]></category>
		<category><![CDATA[Sonoco Products Company]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[StanCorp Financial Group Inc.]]></category>
		<category><![CDATA[Stanley Black & Decker]]></category>
		<category><![CDATA[Stanley Furniture Company Inc]]></category>
		<category><![CDATA[State Street Corporation]]></category>
		<category><![CDATA[Steel Dynamics Inc.]]></category>
		<category><![CDATA[Sterling Bancshares Inc]]></category>
		<category><![CDATA[STI]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[STLD]]></category>
		<category><![CDATA[STLY]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[STT]]></category>
		<category><![CDATA[STX]]></category>
		<category><![CDATA[SunTrust Banks Inc.]]></category>
		<category><![CDATA[SWK]]></category>
		<category><![CDATA[SWKS]]></category>
		<category><![CDATA[SWY]]></category>
		<category><![CDATA[SXT]]></category>
		<category><![CDATA[SY Bancorp Inc.]]></category>
		<category><![CDATA[SYBT]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[T]]></category>
		<category><![CDATA[Taubman Centers Inc.]]></category>
		<category><![CDATA[TAYC]]></category>
		<category><![CDATA[Taylor Capital Group Inc]]></category>
		<category><![CDATA[TBBK]]></category>
		<category><![CDATA[TCB]]></category>
		<category><![CDATA[TCBI]]></category>
		<category><![CDATA[TCF Financial Corporation]]></category>
		<category><![CDATA[TCO]]></category>
		<category><![CDATA[TD AMERITRADE Holding Corporation]]></category>
		<category><![CDATA[TEL]]></category>
		<category><![CDATA[Temple-Inland Inc.]]></category>
		<category><![CDATA[Terex Corporation]]></category>
		<category><![CDATA[TESS]]></category>
		<category><![CDATA[TESSCO Technologies Inc.]]></category>
		<category><![CDATA[TEX]]></category>
		<category><![CDATA[Texas Capital BancShares Inc.]]></category>
		<category><![CDATA[Textron Inc.]]></category>
		<category><![CDATA[The Bancorp Inc]]></category>
		<category><![CDATA[The Bank of New York Mellon Corporation]]></category>
		<category><![CDATA[The Blackstone Group]]></category>
		<category><![CDATA[The Cheesecake Factory Incorporated]]></category>
		<category><![CDATA[The Chubb Corporation]]></category>
		<category><![CDATA[The Coca-Cola Company]]></category>
		<category><![CDATA[The New York Times Company]]></category>
		<category><![CDATA[The Travelers Companies Inc.]]></category>
		<category><![CDATA[Thomas & Betts Corporation]]></category>
		<category><![CDATA[TIN]]></category>
		<category><![CDATA[TNB]]></category>
		<category><![CDATA[Tractor Supply Company]]></category>
		<category><![CDATA[TRIB]]></category>
		<category><![CDATA[Trinity Biotech plc]]></category>
		<category><![CDATA[TRV]]></category>
		<category><![CDATA[TSCO]]></category>
		<category><![CDATA[TXT]]></category>
		<category><![CDATA[Tyco Electronics Limited]]></category>
		<category><![CDATA[UAL]]></category>
		<category><![CDATA[UBNK]]></category>
		<category><![CDATA[Ultratech Inc.]]></category>
		<category><![CDATA[UMPQ]]></category>
		<category><![CDATA[Umpqua Holdings Corporation]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Union Pacific Corporation]]></category>
		<category><![CDATA[United Continental Holdings]]></category>
		<category><![CDATA[United Financial Bancorp]]></category>
		<category><![CDATA[United Rentals Inc]]></category>
		<category><![CDATA[United Technologies Corporation]]></category>
		<category><![CDATA[Unitedhealth Group Inc.]]></category>
		<category><![CDATA[UNP]]></category>
		<category><![CDATA[URI]]></category>
		<category><![CDATA[US Airways Group Inc.]]></category>
		<category><![CDATA[Us Bancorp]]></category>
		<category><![CDATA[USB]]></category>
		<category><![CDATA[UTEK]]></category>
		<category><![CDATA[UTX]]></category>
		<category><![CDATA[VCBI]]></category>
		<category><![CDATA[Verizon Communications Inc.]]></category>
		<category><![CDATA[VF Corporation]]></category>
		<category><![CDATA[VFC]]></category>
		<category><![CDATA[Virginia Commerce Bancorp Inc]]></category>
		<category><![CDATA[Vitran Corp Inc]]></category>
		<category><![CDATA[VIVO]]></category>
		<category><![CDATA[VMW]]></category>
		<category><![CDATA[VMware Inc.]]></category>
		<category><![CDATA[VTNC]]></category>
		<category><![CDATA[VZ]]></category>
		<category><![CDATA[W.W. Grainger Inc]]></category>
		<category><![CDATA[WABC]]></category>
		<category><![CDATA[WAL]]></category>
		<category><![CDATA[Waste Connections Inc.]]></category>
		<category><![CDATA[Watsco Inc.]]></category>
		<category><![CDATA[WCC]]></category>
		<category><![CDATA[WCN]]></category>
		<category><![CDATA[WDC]]></category>
		<category><![CDATA[Wells Fargo & Company]]></category>
		<category><![CDATA[WERN]]></category>
		<category><![CDATA[Werner Enterprises Inc.]]></category>
		<category><![CDATA[WESCO International Inc.]]></category>
		<category><![CDATA[Westamerica BanCorporation]]></category>
		<category><![CDATA[Westell Technologies Inc]]></category>
		<category><![CDATA[Western Alliance Bancorporation]]></category>
		<category><![CDATA[Western Digital Corporation]]></category>
		<category><![CDATA[Westwood Holdings Group Inc]]></category>
		<category><![CDATA[WFC]]></category>
		<category><![CDATA[WHG]]></category>
		<category><![CDATA[Whirlpool Corporation]]></category>
		<category><![CDATA[WHR]]></category>
		<category><![CDATA[Wipro Limited]]></category>
		<category><![CDATA[WIT]]></category>
		<category><![CDATA[WNI]]></category>
		<category><![CDATA[WNS]]></category>
		<category><![CDATA[WNS (Holdings) Limited]]></category>
		<category><![CDATA[WSO]]></category>
		<category><![CDATA[WSTL]]></category>
		<category><![CDATA[WYNN]]></category>
		<category><![CDATA[Wynn Resorts Limited]]></category>
		<category><![CDATA[Xerox Corporation]]></category>
		<category><![CDATA[Xilinx Inc.]]></category>
		<category><![CDATA[XLNX]]></category>
		<category><![CDATA[XRX]]></category>
		<category><![CDATA[XXIA]]></category>
		<category><![CDATA[Yahoo! Inc.]]></category>
		<category><![CDATA[YHOO]]></category>
		<category><![CDATA[ZION]]></category>
		<category><![CDATA[Zions BanCorporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=79251</guid>
		<description><![CDATA[Earnings Preview 7/15/11 Second quarter earnings season is now under way, but things really start to move into high gear next week. There will be 348 firms reporting, and 108 of those are in the S&#38;P 500. By next Friday we should have a very good handle on how the overall earnings season will go. The firms reporting this week are sort of like a who&#8217;s who of U.S. industry including: Apple (AAPL), American Express (AXP), Bank of America (BAC), Caterpillar (CAT), General Electric (GE), International Business Machines (IBM), Intel (INTC), McDonald&#8217;s (MCD), Schlumberger (SLB) and Verizon (VZ). That is an interesting cross section of U.S. business. We have a relatively light economic data calendar, so earnings should be front and center, along with the sovereign debt situations on both ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/18/aapl-2011-second-quarter-earnings-preview-detailed/79251/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DGX) Quest Diagnostics Seeks Regular Colon Test</title>
		<link>http://www.stockbloghub.com/2011/06/29/dgx-quest-diagnostics-seeks-regular-colon-test/77779</link>
		<comments>http://www.stockbloghub.com/2011/06/29/dgx-quest-diagnostics-seeks-regular-colon-test/77779#comments</comments>
		<pubDate>Wed, 29 Jun 2011 16:37:27 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Laboratories & Research]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[FIT]]></category>
		<category><![CDATA[Health Fitness Corporation]]></category>
		<category><![CDATA[Laboratory Corporation of America Holdings]]></category>
		<category><![CDATA[LH]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=77779</guid>
		<description><![CDATA[Leading diagnostics player Quest Diagnostics (DGX) is dissatisfied with the outcome of a nationwide study that it had carried out along with the Colon Cancer Alliance. The data demonstrated that one in three of men and women aged 60-70 have been screened for colon cancer only once. However, the medical guidelines suggest periodic testing after initial screening at age 50 by colonoscopy and other methods. Recommended screening tests include colonoscopy (every 10 years), flexible sigmoidoscopy or virtual colonoscopy (every five years), and fecal occult blood (FOBT) and fecal immunochemical (FIT) tests (annually). Screening at regular intervals is significant as colon cancer is the second leading cause of cancer death in the US. However, it is often treatable when detected in early stages. According to the US Centers for Disease Control ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/29/dgx-quest-diagnostics-seeks-regular-colon-test/77779/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DGX) Quest Diagnostics Launches Gazelle on Android</title>
		<link>http://www.stockbloghub.com/2011/06/23/dgx-quest-diagnostics-launches-gazelle-on-android/77247</link>
		<comments>http://www.stockbloghub.com/2011/06/23/dgx-quest-diagnostics-launches-gazelle-on-android/77247#comments</comments>
		<pubDate>Thu, 23 Jun 2011 16:08:33 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Laboratories & Research]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[Apple Inc.]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[GOOG]]></category>
		<category><![CDATA[Google Inc.]]></category>
		<category><![CDATA[Laboratory Corporation of America Holdings]]></category>
		<category><![CDATA[LH]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>
		<category><![CDATA[Research In Motion Limited]]></category>
		<category><![CDATA[RIMM]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=77247</guid>
		<description><![CDATA[Quest Diagnostics (DGX),a leading player in the diagnostic testing market, recently launched a new version of its mobile health platform, Gazelle. The company claims that this latest version will work in sync with Google’s (GOOG) fast-growing Android smartphone operating system. Currently, Gazelle is available for free at Gazelleapp.com as well as in the Android Market at market.android.com. Earlier, in October 2010, Gazelle was first introduced to operate under Apple’s (AAPL) iPhone and Research In Motion’s (RIMM) BlackBerry platforms. This application enables the patients to see, store and share their vital health information including Quest Diagnostics laboratory test results with the healthcare providers via mail or fax. With the latest version of Gazelle, which is compatible with Google Android, users in 33 states including the District of Columbia will be able ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/23/dgx-quest-diagnostics-launches-gazelle-on-android/77247/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(LH) Laboratory Corporation of America Holdings Extends Orchid Tender Offer</title>
		<link>http://www.stockbloghub.com/2011/06/19/lh-laboratory-corporation-of-america-holdings-extends-orchid-tender-offer/76735</link>
		<comments>http://www.stockbloghub.com/2011/06/19/lh-laboratory-corporation-of-america-holdings-extends-orchid-tender-offer/76735#comments</comments>
		<pubDate>Sun, 19 Jun 2011 13:34:08 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Laboratories & Research]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[First Trust Large Cap Gr Opp AlphaDEX]]></category>
		<category><![CDATA[FTC]]></category>
		<category><![CDATA[Laboratory Corporation of America Holdings]]></category>
		<category><![CDATA[LH]]></category>
		<category><![CDATA[ORCH]]></category>
		<category><![CDATA[Orchid Cellmark Inc.]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=76735</guid>
		<description><![CDATA[Laboratory Corporation of America Holdings (LH) has decided to extend the tender offer for Orchid Cellmark (ORCH) till July 15, 2011. Earlier, in May 2011, the company received a request from the Federal Trade Commission (FTC) for some additional information related to the transaction. LabCorp is cooperating with the FTC on this issue. Till date about 88.2% of the outstanding shares of Orchid have been tendered. In April, LabCorp had decided to acquire Orchid Cellmark for $2.80 per share in cash or a total $85.4 million. After taking into account Orchid Cellmark’s cash balance LabCorp’s net payable comes to $65.6 million. Orchid Cellmark provides DNA testing services targeted towards forensic and family relationship applications on a global basis. Based on this deal, LabCorp will be able to develop a command ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/19/lh-laboratory-corporation-of-america-holdings-extends-orchid-tender-offer/76735/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DGX) Quest Diagnostics Expedites Celera Acquisition</title>
		<link>http://www.stockbloghub.com/2011/04/15/dgx-quest-diagnostics-expedites-celera-acquisition/71625</link>
		<comments>http://www.stockbloghub.com/2011/04/15/dgx-quest-diagnostics-expedites-celera-acquisition/71625#comments</comments>
		<pubDate>Fri, 15 Apr 2011 17:01:06 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Laboratories & Research]]></category>
		<category><![CDATA[Celera Corporation]]></category>
		<category><![CDATA[CRA]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[Laboratory Corporation of America Holdings]]></category>
		<category><![CDATA[LH]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=71625</guid>
		<description><![CDATA[Leading diagnostics player, Quest Diagnostics (DGX) took a step forward toward the proposed acquisition of Celera Corporation (CRA). The company recently announced that the waiting period under the HSR Act has expired, though some other conditions are yet to be met. The tender offer to acquire the shares of Celera is supposed to close on April 25, 2011, unless extended further. Last month, Quest decided to acquire Celera for $8 per share, through which the company plans to strengthen its footing in molecular diagnostics discovery and development. Celera’s proprietary genetic tests, pipeline of biomarkers, along with esoteric cardiovascular test, offered by Berkeley HeartLab should drive Quest’s revenues. Celera, with revenues of $128 million in 2010, is expected to add just over 1% to Quest’s 2011 revenue growth. The transaction, to ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/04/15/dgx-quest-diagnostics-expedites-celera-acquisition/71625/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DGX) Quest Diagnostics &#8211; Bear of the Day</title>
		<link>http://www.stockbloghub.com/2010/08/02/dgx-quest-diagnostics-bear-of-the-day/45587</link>
		<comments>http://www.stockbloghub.com/2010/08/02/dgx-quest-diagnostics-bear-of-the-day/45587#comments</comments>
		<pubDate>Mon, 02 Aug 2010 14:51:20 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Laboratories & Research]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=45587</guid>
		<description><![CDATA[Quest Diagnostics (DGX) second-quarter EPS of $0.89 beats the Zacks Consensus Estimate by a penny and the year-ago quarters by 7 cents. However, revenues declined 1.4% to $1.9 billion, driven by a decline in both volume and pricing. Meanwhile, the company proactively negotiated contracts with some MCOs at reduced prices. Although this gives more visibility, revenue per requisition was affected in the near term. Quest is adopting strategies such as suitable acquisitions Incorporatedreased sales force and targeting additional geographies to drive its top line. However, we believe in the near term volume and pricing outlook will continue to remain under pressure unless the economic scenario improves. As a result, we lower our estimates for the company and downgrade it to Underperform. Zacks Investment Research]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/08/02/dgx-quest-diagnostics-bear-of-the-day/45587/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DGX) Quest Diagnostics Beats Expectations but Revenues are Unchanged</title>
		<link>http://www.stockbloghub.com/2010/04/21/dgx-quest-diagnostics-beats-expectations-but-revenues-are-unchanged/34559</link>
		<comments>http://www.stockbloghub.com/2010/04/21/dgx-quest-diagnostics-beats-expectations-but-revenues-are-unchanged/34559#comments</comments>
		<pubDate>Wed, 21 Apr 2010 20:58:23 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Laboratories & Research]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=34559</guid>
		<description><![CDATA[Quest Diagnostics (DGX) reported first quarter fiscal 2010 earnings per share (EPS) of 89 cents, unchanged from the year-ago period. However, excluding the impact of severe weather conditions and charges associated with workforce reduction Quest’s EPS came in at $1.00, beating the Zacks Consensus Estimate by a couple of cents. Revenues for the quarter remained unchanged at $1.8 billion. However, the EPS improved compared to the year-ago period due to the 4.4% reduction in the number of outstanding shares. Clinical testing revenues, which account for most of Quest’s sales, declined 0.4% compared to the prior year. While underlying volume in clinical testing (measured by the number of requisitions) during the quarter declined 2.6%, revenue per requisition increased 2.3% compared to the year-ago period. Quest witnessed increased demand for gene-based and ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/04/21/dgx-quest-diagnostics-beats-expectations-but-revenues-are-unchanged/34559/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DGX) Why Healthcare Reform Should Help The Diagnostics Industry</title>
		<link>http://www.stockbloghub.com/2010/04/01/dgx-why-healthcare-reform-should-help-the-diagnostics-industry/32633</link>
		<comments>http://www.stockbloghub.com/2010/04/01/dgx-why-healthcare-reform-should-help-the-diagnostics-industry/32633#comments</comments>
		<pubDate>Thu, 01 Apr 2010 21:37:50 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Laboratories & Research]]></category>
		<category><![CDATA[Bio-Reference Laboratories Inc]]></category>
		<category><![CDATA[BRLI]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[Genomic Health Inc.]]></category>
		<category><![CDATA[Genoptix]]></category>
		<category><![CDATA[GHDX]]></category>
		<category><![CDATA[GXDX]]></category>
		<category><![CDATA[Laboratory Corporation of America Holdings]]></category>
		<category><![CDATA[LH]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=32633</guid>
		<description><![CDATA[America seems to be divided into two camps… Not blue states versus red states. Not Yankees fans versus Red Sox fans (although why you’d be the latter I’ll never understand). Not even people who support the new healthcare reform bill versus those who are opposed to it. Rather, I’m talking about the difference between people who run to the doctor for every little ache and pain, compared with those who wouldn’t go within 50 yards of a doctor’s office even if their internal organs suddenly became external… The Diagnostics Industry: More Healthcare Coverage Means More Business My family and I try to stay out of doctor’s offices. This has been the case, ever since a routine visit to get my six-year-old son some orthopedics in his shoes turned into scheduled ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/04/01/dgx-why-healthcare-reform-should-help-the-diagnostics-industry/32633/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DGX) Quest Diagnostics Beats Expectations &#8211; Guides In-Line</title>
		<link>http://www.stockbloghub.com/2010/01/25/dgx-quest-diagnostics-beats-expectations-guides-in-line/25900</link>
		<comments>http://www.stockbloghub.com/2010/01/25/dgx-quest-diagnostics-beats-expectations-guides-in-line/25900#comments</comments>
		<pubDate>Mon, 25 Jan 2010 20:52:44 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Laboratories & Research]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=25900</guid>
		<description><![CDATA[Quest Diagnostics’ (DGX) fourth quarter earnings per share of 97 cents beat both the Zacks Consensus Estimate by a penny and the 87 cents reported in the year-ago period. Revenues for the quarter increased 2.7% to $1.8 billion. Clinical testing revenues, which account for most of Quest’s sales Incorporatedreased 2.3% compared to the prior year. For the full year, while revenues increased 2.8% to $7.5 billion, earnings per share recorded a rise of 20% to $3.88. The growth in revenues was primarily driven by increased demand for innovative gene-based and esoteric tests Incorporatedluding cancer diagnostics. Among the latest initiatives, the company introduced a new blood test that identifies changes in DNA associated with colorectal cancer. While underlying volume in clinical testing (measured by the number of requisitions) during the quarter ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/01/25/dgx-quest-diagnostics-beats-expectations-guides-in-line/25900/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DGX) Quest Diagnostics Outperforms &#8211; Raises Outlook</title>
		<link>http://www.stockbloghub.com/2009/10/21/dgx-quest-diagnostics-outperforms-raises-outlook/18377</link>
		<comments>http://www.stockbloghub.com/2009/10/21/dgx-quest-diagnostics-outperforms-raises-outlook/18377#comments</comments>
		<pubDate>Wed, 21 Oct 2009 23:47:48 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Laboratories & Research]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=18377</guid>
		<description><![CDATA[Quest Diagnostics’ (DGX) third quarter earnings per share of $1.02 beat the Zacks Consensus Estimate of 96 cents and 86 cents reported in the year ago period. Revenues for the quarter increased 3.9% to $1.9 billion. Clinical testing revenues, which account for most of Quest’s sales increased 4.3% compared to the prior year. Quest Diagnostics witnessed strong testing demand in the areas of cancer, allergies, and vitamin D levels. Among the latest initiatives, the company introduced the first commercial test for the H1N1 flu virus authorized by the US Food and Drug Administration (FDA) for emergency use, and launched a saliva-based genetic test that helps physicians predict response to the blood thinner Plavix. While underlying volume in clinical testing (measured by the number of requisitions), continued to grow in the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/10/21/dgx-quest-diagnostics-outperforms-raises-outlook/18377/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DGX) Quest Diagnostics Incorporated &#8211; Growth And Income &#8211; Zacks Rank Buy</title>
		<link>http://www.stockbloghub.com/2009/04/30/dgx-quest-diagnostics-incorporated-growth-and-income-zacks-rank-buy/6313</link>
		<comments>http://www.stockbloghub.com/2009/04/30/dgx-quest-diagnostics-incorporated-growth-and-income-zacks-rank-buy/6313#comments</comments>
		<pubDate>Thu, 30 Apr 2009 20:31:54 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Laboratories & Research]]></category>
		<category><![CDATA[DGX]]></category>
		<category><![CDATA[Quest Diagnostics Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=6313</guid>
		<description><![CDATA[Quest Diagnostics Incorporated (DGX) recently delivered strong first-quarter results. Earnings per share of 89 cents topped the year-prior 72 cents and exceeded analysts&#8217; expectations by 8.5%. Company Description Quest Diagnostics Incorporated provides diagnostic testing, information and services for patients and doctors all over the world. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers. Quest Diagnostics also provides interpretive consultation through its extensive medical and scientific staff. The company is consider to be a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. An Excellent Quarter Quest Diagnostics recently delivered strong first-quarter results. Earnings per share of 89 cents topped the year-prior 72 cents and exceeded analysts&#8217; expectations by 8.5%. First quarter ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/04/30/dgx-quest-diagnostics-incorporated-growth-and-income-zacks-rank-buy/6313/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
